Patent Grant
12005217
This application relates generally to skin treatment, and more specifically, to apparatuses, systems and methods for treating a person's skin.
Abrasion of the outer layer or epidermis of the skin is desirable to smooth or blend scars, blemishes or other skin conditions that may be caused by, for example, sun exposure, acne, other skin disorders, aging and/or the like. Standard techniques used to abrade the skin have generally been separated into two fields that are commonly referred to as dermabrasion and microdermabrasion. In both techniques, portions of the epidermis (e.g., the stratum corneum) are removed. As part of its normal regeneration function, the body then replaces the lost skin cells, resulting in a new outer layer of skin. Additionally, despite the mild edema and erythema associated with the procedures, the skin eventually looks and feels smoother than prior to the treatment because of the new outer layer of skin.
Dermabrasion generally refers to a procedure in which the outer surface of the skin is removed due to mechanical rubbing by a handpiece with an abrasive element that is often in the form of a burr, wheel, disc or the like. This process tends to be messy and painful, sometimes necessitating the administration of a local anesthetic to the person being treated. In general, dermabrasion leaves the skin red and raw-looking. The removed skin can take several months to regrow and heal. Recent efforts have led to the use of lasers instead of abrasive elements, resulting in less bleeding. However, the pain and messiness of such procedures normally remain.
Efforts have been made to decrease the mess caused by the process waste, such as, for example, removed skin, blood, other debris and the like, by adding a suction element. As the process waste is drawn into the suction opening, skin that has not been removed is also pulled against the grit surrounding the suction opening, so the procedure remains relatively messy due to the abrasion that takes place outside of the handpiece by the grit.
In general, microdermabrasion refers generally to a procedure in which the surface of the skin is removed by mechanical rubbing using a handpiece that can discharge a stream of sand or grit. For example, a handpiece can be used to direct a fluid containing crystals of aluminum oxide, sodium chloride and/or sodium bicarbonate. The velocity and momentum of the grit helps wear away cell layers of the skin with each pass of the handpiece. Alternatively, new “crystal-free” microdermabrasion techniques utilize a diamond-tipped handpiece without a stream of grit.
Efforts to add a suction element have been more successful in microdermabrasion than in dermabrasion, because the handpiece applying the stream of grit is more controllable to a localized area. That is, as the removed skin is drawn into the suction opening, skin that has not been removed is also pulled towards the handpiece where it is treated with the grit stream, allowing for simultaneous local treatment and suction.
Microdermabrasion typically removes moisture from the skin. Thus, the procedure is generally followed by the application of moisturizing creams, other agents and/or other materials. However, similar to topical application of moisturizing creams prior to microdermabrasion, the moisturizing elements only work as deep as the active ingredients can passively migrate through the remaining epidermis.
According to certain embodiments of the present application, a handpiece assembly for treating a skin surface comprises a recess configured to receive a cartridge or other container. The cartridge or other container comprises one or more treatment materials, such as, for example, human growth factors, cytokines, soluble collagen, antioxidants, matrix proteins, serums, water (e.g., distilled, tap water, filtered, etc.), saline, other dilutants or dissolvents, vitamins, chemical exfoliation agents, lotions, soothing agents, brightening or lightening agents, peptides, acids, anesthetics, medicants, other non-active or active compounds, other fluids or materials, combination or mixtures thereof and/or any other substance. In one embodiment, the handpiece assembly comprises a valve or other flow control device or feature to enable a user to selectively regulate a flowrate of a treatment material through the handpiece assembly. In other embodiments, the cartridge or other container comprises an inlet configured to be in fluid communication with water, saline, another dilutant or dissolvent or another fluid. The water, saline, another dilutant or dissolvent or another fluid is configured to be delivered through the inlet and to an interior of the cartridge so as to mix or combine with a treatment material contained therein. In some embodiments, the treatment material contained within the cartridge or container is a liquid, solid, gel, granulated material or concentrated solution. In some embodiments, one or more treatment fluids are conveyed from an outlet of the cartridge or container to a tip attached to a distal end of the handpiece assembly.
According to other embodiments, a treatment material disposed on or near the tip of the handpiece assembly is configured to be mixed or combined with water, saline or another fluid being delivered through the handpiece assembly to create a treatment fluid. In certain embodiments, the treatment material is provided as a solid, semi-solid, gel, granulated material or concentrated fluid or solution. In some arrangements, the treatment material is positioned within a recess of the tip, between the tip and a main body portion of the handpiece assembly or within the main body portion of the handpiece assembly. In some embodiments, water, saline, treatment fluid or other fluid being conveyed through the handpiece assembly is configured to be heated.
According to certain embodiments of the present application, a device for treating a skin surface comprises a handpiece assembly having a distal end and a proximal end. The handpiece assembly comprises at least one delivery conduit and at least one waste conduit. The handpiece assembly further comprising a recess or other opening configured to receive a cartridge or other container having an interior cavity. In one embodiment, the interior cavity of the cartridge is placed in fluid communication with the fluid delivery conduit when the cartridge is secured within the recess. The device additionally includes a tip positioned along the distal end of the handpiece assembly, such that the tip is configured to contact the skin surface. In certain embodiments, the tip comprises a peripheral lip, a first opening in fluid communication with the fluid delivery conduit and a second opening in fluid communication with the waste conduit and an abrasive element. The first opening, the second opening and the abrasive element are generally positioned along an interior of the peripheral lip. In one embodiment, the waste conduit is configured to be in fluid communication with a vacuum to selectively remove debris away from the tip. In other arrangements, the delivery conduit is placed in fluid communication with the waste conduit and the vacuum when the peripheral lip contacts a skin surface.
In certain arrangements, the device further includes a valve generally positioned between the interior cavity of the cartridge and the fluid delivery conduit. The valve can be adapted to control the flowrate of a fluid being conveyed from the interior cavity of the cartridge to the tip. In other embodiments, the handpiece assembly comprises an adjustable intermediate space positioned generally between the interior cavity of the cartridge and the fluid delivery conduit. In one arrangement, a volume of the adjustable intermediate space can be selectively modified by moving an actuator on the handpiece assembly. In other configurations, the handpiece assembly comprises a stem in fluid communication with the fluid delivery conduit. The stem can be adapted to extend into the interior cavity of a cartridge when the cartridge is positioned with the recess of the handpiece assembly. In other embodiments, the tip is selectively removable from the handpiece assembly. In one arrangement, the abrasive element comprises a plurality of posts, other protruding members, a spiral-shaped ridge, an abrasive surface, a foam pad, another type of pad and/or the like. In some arrangements, the device further includes a heating element configured to selectively heat a fluid being conveyed through the delivery conduit, another interior passage or conduit of the handpiece assembly, the tip, an inlet line and/or the like. In other embodiments, the cartridge comprises an inlet configured to be placed in fluid communication with a delivery source.
According to other arrangements, a skin treatment system includes a handpiece assembly having a distal end and a proximal end. The handpiece assembly comprises a fluid delivery conduit. In one embodiment, the handpiece assembly comprises a first portion and a second portion, with the first portion being selectively movable relative to the second portion. The skin treatment system further includes a tip adapted to contact skin and positioned on the distal end of the handpiece assembly. In one embodiment, the tip comprises a first opening, which is in fluid communication with the fluid delivery conduit, and an abrasive element. The system further comprises an intermediate space generally defined between the first and second portions of the handpiece assembly. Movement of the first portion with respect to the second portion can modify the volume of the intermediate space and generally control the flowrate of a fluid being conveyed through the fluid delivery conduit. In some embodiments, the system further includes an actuator on the handpiece assembly for moving the first portion relative to the second portion.
According to other embodiments, movement of the first portion with respect to the second portion is produced by rotating the second portion relative to the first portion. In some arrangements, the tip is selectively removable from the second portion. In another adaptation, the tip comprises a plurality of posts or protruding members configured to treat skin. In other arrangements, the tip comprises one or more ridges (e.g., spiral-shaped ridges), abrasive surfaces or elements and/or other features or components configured to treat skin. In certain embodiments, the handpiece assembly further comprises a waste channel in fluid communication with a second opening in the tip. In another embodiment, the handpiece assembly includes a recessed area configured to receive a cartridge comprising at least one treatment fluid or material. In other arrangements, the cartridge includes an interior portion which is at least partially defined by a membrane. The membrane can be configured to be pierced by a hollow spike of the first portion of the handpiece assembly when the cartridge is properly inserted within the recessed area, so that the hollow spike is placed in fluid communication with the delivery channel. In certain configurations, the interior portion of the cartridge comprises human growth factors, cytokines, soluble collagen, antioxidants, matrix proteins, serums, water (e.g., distilled, tap water, filtered, etc.), saline, other dilutants or dissolvents, vitamins, chemical exfoliation agents, lotions, soothing agents, brightening or lightening agents, peptides, acids, anesthetics, medicants, other non-active or active compounds, other fluids or materials, combination or mixtures thereof and/or any other substance. In other arrangements, the device comprises a heater configured to selectively heat a fluid being conveyed through the fluid delivery conduit toward the tip.
According to certain embodiments, a method of providing a treatment fluid to a skin surface while treating said skin surface with a handpiece device includes providing at least one treatment material on or within a handpiece device. In one arrangement, a tip is configured to be removably positioned along a distal end of a main body portion of the handpiece assembly. The tip can be adapted to abrade or otherwise treat skin when moved relative to a skin surface. The treatment method additionally includes directing a first fluid through a delivery passage of the handpiece assembly so that said delivery passage generally contacts at least one treatment material of the tip. In some arrangements, the treatment material is configured to at least partially dissolve, dilute or combine with the first fluid so as to create a desired treatment fluid. Further, the treatment fluid can be configured to be provided to the tip and to the skin surface being treated while a distal end of the tip is being translated over said skin surface.
In some arrangements, the treatment material comprises a solid, granular material, gel or concentrated solution and/or any other material. In other embodiments, the first fluid comprises water (e.g., sterile, tap, distilled, filtered, etc.), saline, other dilutants or dissolvents and/or any other fluid. In other arrangements, the treatment fluid comprises human growth factors, cytokines, soluble collagen, antioxidants or matrix proteins. In another embodiment, the treatment material is positioned in or near the tip, such as, for example, within a post, other protruding member, other recess, underneath the tip and/or like. In other arrangements, the treatment material comprises a disc, tablet, capsule, granular material, gel and/or the like. In one embodiment, the treatment material is configured to be positioned within a cage or other porous container. In other arrangements, the disc, table, capsule or other treatment material is configured to be secured generally between the main body portion and the tip of the handpiece assembly. In one configuration, the method further includes regulating a flowrate of the first fluid by selectively controlling a valve on the handpiece assembly. In another arrangement, the method additionally includes selectively heating the first fluid using a heating member positioned in thermal communication with the delivery passage of the handpiece assembly. In some embodiments, the treatment material is positioned within a cartridge which is configured to be removably secured to a receiving area of the handpiece assembly.
According to some embodiments disclosed in the present application, a device for treating the skin comprises a handpiece assembly having a distal end and a proximal end, a cartridge comprising an interior cavity and a tip on the distal end of the handpiece assembly. The handpiece assembly includes a fluid delivery conduit and a waste conduit. In addition, the cartridge is coupled to the handpiece assembly, with the interior cavity of the cartridge being in fluid communication with the fluid delivery conduit. Further, the tip is configured to contact the skin. The tip comprises a peripheral lip, a first opening in fluid communication with the fluid delivery conduit, a second opening in fluid communication with the waste conduit and an abrasive element. The first opening, the second opening and the abrasive element of the tip are generally positioned within the peripheral lip.
In some embodiments, the device further comprising a valve positioned between the interior cavity of the cartridge and the fluid delivery conduit. In one embodiment, the handpiece assembly comprises an adjustable intermediate space positioned generally between the interior cavity of the cartridge and the fluid delivery conduit. In another arrangement, a volume of the adjustable intermediate space can be selectively modified by moving an actuator on the handpiece assembly. In other embodiments, the handpiece assembly comprises a recessed area configured to receive the cartridge.
According to other embodiments, the handpiece assembly comprises a stem that is in fluid communication with the fluid delivery conduit as the stem is configured to extend into the interior cavity of a cartridge when the cartridge is coupled to the handpiece assembly. In another embodiment, the tip is selectively removable from the handpiece assembly. In some arrangements, the abrasive element comprises a plurality of protruding members. In other embodiments, the tip comprises an abrasive edge.
According to another embodiment, a system for treating the skin comprises a handpiece assembly having a distal end and a proximal end and a tip on the distal end of the handpiece assembly configured to contact the skin. The handpiece assembly includes a fluid delivery conduit and first and second portions. Further, the tip includes a first opening in fluid communication with the fluid delivery conduit and an abrasive element. An intermediate space generally defined between the first and second portions of the handpiece assembly is in fluid communication with the fluid delivery conduit. In one embodiment, movement of the first portion with respect to the second portion modifies the volume of the intermediate space to control a flowrate through the fluid delivery conduit. The system further comprises an actuator on the handpiece assembly for actuating movement between the first portion and the second portion.
In some embodiments, movement of the first portion with respect to the second portion is produced by rotating the second portion relative to the first portion. In other embodiments, the tip is selectively removable from the second portion. In still other arrangements, the tip comprises a plurality of protruding members configured to treat skin. In another embodiment, the tip comprises an abrasive surface configured to treat skin.
According to some embodiments, the handpiece assembly further comprises a waste channel in fluid communication with a second opening in the tip. In another arrangement, the handpiece assembly includes a recessed area configured to receive a cartridge comprising at least one treatment fluid or material. In other embodiments, the cartridge includes an interior portion at least partially defined by a membrane. The membrane is configured to be pierced by a hollow spike of the first portion of the handpiece assembly. Further, the hollow spike is in fluid communication with the delivery channel. In one embodiment, the interior portion of the cartridge comprises human growth factors, cytokines, soluble collagen, antioxidants and/or matrix proteins.
According to other embodiments, the present application discloses a method for treating the skin of a patient with a skin treatment device having a working end that includes an abrading structure configured to engage and abrade skin. The method includes placing the working end of the skin treatment device against the skin of the patient, translating the working end over the skin to abrade a skin surface, providing a treatment fluid to the skin through an opening in the working end and aspirating skin debris from the skin surface through an aspiration opening in the working end of the skin treatment device. In some embodiments, the treatment fluid comprises human growth factors, cytokines, soluble collagen, antioxidants and/or matrix proteins.
According to some embodiments disclosed in the present application, a device for treating the skin comprises a handpiece assembly having a distal end and a proximal end. The handpiece assembly includes a fluid delivery conduit and a waste conduit. In addition, the handpiece assembly is adapted to receive a cartridge having an interior cavity. Further, the device includes a tip attached to the distal end of the handpiece assembly and comprising a surface configured to treat skin. The waste conduit is configured to be in fluid communication with a vacuum source and the fluid delivery conduit is configured to be in fluid communication with an interior cavity of a cartridge when a cartridge is secured to the handpiece assembly.
In some embodiments, the handpiece assembly comprises a flow control feature configured to selectively regulate a flowrate through the fluid delivery conduit. In another arrangement, the handpiece assembly includes a main body portion and an adjustable portion attached to the main body portion. The flow control feature can comprise an adjustable intermediate space generally located between the main body portion and the adjustable portion. In other embodiments, a volume of the adjustable intermediate space can be selectively modified by moving the main body portion relative to the adjustable portion of the handpiece assembly.
In one embodiment, the handpiece assembly comprises a recessed area configured to secure a cartridge. In another arrangement, the handpiece assembly comprises a stem adapted to access an interior cavity of a cartridge when a cartridge is secured to the handpiece assembly. According to some embodiments, the tip is selectively removable from the handpiece assembly. In other embodiments, the tip comprises a plurality of protruding members configured to treat skin. In still other arrangements, the tip comprises an abrasive surface configured to treat skin.
According to another embodiment, a system for treating the skin includes a handpiece assembly. The handpiece assembly comprises a tip configured to treat skin, a first portion and a second portion. The first portion includes a delivery conduit, which has a first longitudinal axis, and is configured to be in fluid communication with at least one fluid source. Further, the second portion includes a distal end and a proximal end, with the proximal end being attached to the main body portion and the distal end being attached to the tip. The second portion includes a delivery channel having a second longitudinal axis and being in fluid communication with the tip and the delivery conduit. In addition, the second portion further comprises a removal channel being in fluid communication with the tip and a suction source. In some embodiments, an intermediate space is generally defined between the first and second portions of the handpiece assembly. Such an intermediate space is in fluid communication with the delivery conduit of the first portion and the delivery channel of the second portion. Further, a volume of the intermediate space is configured to be adjusted by selectively modifying a separation distance between the first portion and the second portion. Accordingly, a flowrate from a fluid source to the tip can be selectively controlled by modifying the separation distance between the first portion and the second portion.
In some embodiments, the separation distance between the first portion and the second portion is modified by rotating the second portion relative to the first portion. In other arrangements, the first longitudinal axis of the delivery conduit is generally offset with the second longitudinal axis of the delivery channel. In one embodiment, the tip is selectively removable from the second portion.
According to some embodiments, the tip comprises a plurality of protruding members configured to treat skin. In other embodiments, the tip comprises an abrasive surface configured to treat skin. In one embodiment, the first portion further comprises a waste channel in fluid communication with the removal channel of the second portion. In another arrangement, the first portion includes a recessed area configured to receive a cartridge comprising at least one treatment fluid or material. In some embodiments, the cartridge includes an interior portion at least partially defined by a membrane which is configured to be pierced by a hollow spike of the first portion of the handpiece assembly. The hollow spike is in fluid communication with the delivery channel. According to other embodiments, the cartridge the interior portion of the cartridge comprises human growth factors, cytokines, soluble collagen, antioxidants or matrix proteins.
According to other embodiments disclosed in the present application, a method of treating the skin comprises providing a handpiece assembly comprising a body and a tip having a distal end. The handpiece assembly includes a delivery conduit and a waste conduit that are in fluid communication with the distal end of the tip. The method further includes placing the delivery conduit of the handpiece assembly in fluid communication with a fluid source for providing at least one treatment fluid to the distal end of the tip and placing the waste conduit of the handpiece assembly in fluid communication with a suction source for removing waste materials from the distal end of the tip. In addition, the method comprises moving the handpiece assembly along a person's skin and activating the suction source to remove a volume of waste materials from the distal end of the tip and to simultaneously deliver a volume of the treatment fluid to the distal end of the tip. In one embodiment, the flowrate at which treatment fluids and/or other materials are delivered to the tip can be varied by a valve or other flow control feature of the handpiece assembly. In some embodiments, the treatment fluid comprises human growth factors, cytokines, soluble collagen, antioxidants, matrix proteins, serums, water (e.g., distilled, tap water, filtered, etc.), saline, other dilutants or dissolvents, vitamins, chemical exfoliation agents, lotions, soothing agents, brightening or lightening agents (e.g., kojic acid), peptides, acids, anesthetics, medicants, other non-active or active compounds, other fluids or materials, combination or mixtures thereof and/or any other substance.
These and other features, aspects and advantages of the present inventions are described with reference to drawings of certain preferred embodiments, which are intended to illustrate, but not to limit, the present inventions. The drawings include fifty-eight (58) figures. It is to be understood that the attached drawings are for the purpose of illustrating concepts of the present inventions and may not be to scale.
With continued reference to
In alternative embodiments, such as, for example, those discussed herein with reference to
In addition, as illustrated in
With reference to
In other arrangements, two or more different cartridges 200 can be used during a skin treatment procedure. For example, a particular procedure may require the contents (e.g., serums, proteins, brightening or lightening agents, peptides, other fluids or substances, etc.) of two or more different cartridges 200. Thus, a user can load and/or unload a combination of cartridges 200 or other containers within a handpiece assembly 100 during a treatment procedure, either at the same time or sequentially (e.g., one after another). With continued reference to
As illustrated in
In the embodiment illustrated in
The cartridge 200 can include one or more suitable materials, such as, for example, glass, metals (e.g., stainless steel), plastic, other synthetic or natural materials and/or the like. In some embodiments, for instance, a nozzle portion 210 comprising aluminum or other metal is crimped onto a glass main cylindrical portion 206 of the cartridge 200. However, the nozzle portion 210 and the main cylindrical portion 206 of the cartridge 200 can comprise any other materials. However, the nozzle portion 210 can be attached to the cylindrical portion 206 using one or more other methods or devices, such as, for example, a threaded connection, snap connection, adhesives, other fasteners and/or the like. In still other embodiments, the cartridge 200 may include more or fewer portions, compartments, features and/or the like, as desired or required.
With continued reference to
In the illustrated embodiment, the spike 126 includes an angled or sloped tip 128 to further facilitate the piercing or puncturing of the cartridge's septum 214 or other sealing member. Although not illustrated herein, the handpiece assembly 100 can include one or more other needles that are configured to penetrate into the interior of a cartridge 200. For example, one or more vent needles can be used to facilitate the removal of fluids and/or other materials from a cartridge 200 which has been loaded into a handpiece assembly 100.
As discussed, the cartridge 200 can be sized, shaped and otherwise configured to snugly or generally snugly fit within the handpiece assembly 100. Therefore, in some arrangements, the cartridge 200 is secured to the handpiece assembly 100 by friction or by the generally tight tolerances of the recess 111 of the handpiece assembly 100. In
In other embodiments, however, a cartridge 200 can be secured to one or more other portions of a handpiece assembly 100. In addition, the handpiece assembly 100 can include one or more other methods or devices for securing a cartridge 200. For example, the handpiece assembly 100 can include tabs, flanges, other protrusion members and/or any other features or items that help positively engage one or more portions of the cartridge 200 positioned therein. In some embodiments, delivery of a cartridge 200 to a desired depth of the recess 111 or other receiving area of the handpiece assembly 100 can produce an audible click, a positive engagement mechanism and/or the like. Such features can help notify the user that a cartridge 200 has been property secured within the handpiece assembly 100. In other arrangements, a separate device, such as, as a locking cap, strap or other member can be used to ensure that the cartridge 200 remains in fluid communication with the spike 126 and within the recess 111 or other desired receiving location of the handpiece assembly 100 during use.
In some embodiments, the longitudinal axes of the delivery conduit 124 and the spike 126 can be offset (e.g., generally not aligned) with each other. This can permit the width 143A, 143B or other separation distance between the main body portion 110 and the adjustable distal portion 130 to be selectively varied. As discussed in greater detail herein, this can help modify the hydraulic characteristics of fluids and/or other materials being conveyed from the spike 126 to the delivery conduit 124, and thus, from a cartridge 200 or other fluid source to the tip 160 of the handpiece assembly 100. In some embodiments, the longitudinal axes of the delivery conduit 124 and the spike 126 remain offset as the adjustable distal portion 130 is rotated or otherwise moved relative to the main body portion 110.
In the illustrated embodiment, the distance between the recessed annular ring 118 of the main body portion 110 and the interface 119 between the main body portion 110 and the adjustable distal portion 130 varies depending on the circumferential position of the annular ring 118. In other words, by rotating the adjustable distal portion 130 relative to the main body portion 110, the distance between these portions 130, 110 can be selectively adjusted.
With continued reference to
Alternatively, as illustrated in
With continued reference to
In the embodiment illustrated in
However, a handpiece assembly 100 can include one or more other methods of selecting a desired flowrate of fluids and/or other materials therethrough. For example, in some embodiments, the handpiece assembly 100 includes one or more dials, knobs, buttons and/or other devices or features for adjusting the flowrate. Such controllers can be graduated so as to permit a user to select a specific flowrate or relative flow setting (e.g., “HIGH,” “MEDIUM,” “LOW,” etc.). In other arrangements, the handpiece assembly 100 comprises a display (e.g., LED, LCD, etc.) that is adapted to provide information regarding a current flowrate or setting. Further, such a display can be configured to permit users to make flowrate adjustments (e.g., touchscreen display). Further, selection devices or features (e.g., knobs, buttons, dials, etc.) and/or displays can be positioned on the handpiece assembly 100. Alternatively, the controllers can be separate from the handpiece assembly. For example, such devices or features can be connected to the assembly through one or more hardwired and/or wireless connections (e.g., cable, Ethernet line, radio frequency, Bluetooth, Wi-Fi, etc.).
In other embodiments, a handpiece assembly 100 includes one or more different methods and/or devices for controlling the flowrate of fluids or other materials from a cartridge 200 toward the tip 160. For example, the handpiece assembly 100 can comprise different types of flow control valves or devices than those disclosed herein. Regardless of the exact flow control method or device used, it may be desirable to provide users with the ability to selectively regulate the rate at which serums, other fluids or materials and/or the like are delivered from a cartridge 200 to the tip 160 of the handpiece assembly 100. This can further enhance a particular skin treatment procedure by allowing a desired volume of fluids or other materials to be delivered to the treatment surface (e.g., skin-tip interface). For instance, during the initial exfoliation phase, a relatively high volume of serum or other lubricating fluids may be desired. However, during subsequent stages of a treatment procedure, a reduced flowrate of fluids and/or other substances may be desired or required.
With continued reference to
As depicted in
With continued reference to the cross-sectional views of
In some embodiments, the main body portion 110 of the handpiece assembly 100 includes a discharge nozzle 180 or port. As illustrated in
According to some embodiments, the conduit 190 or other channel (e.g., flexible tubing or hose) to which the handpiece assembly 100 connect are in fluid communication with a vacuum or other suction source (e.g., pump, other fluid transfer device, etc.). Thus, exfoliated skin, spent fluids and/or other waste materials can be transported away from the distal end 161 of the tip 160 to a canister (not shown) or other waste source. The rate of transfer of such waste materials can depend on one or more factors, such as, for example, the setting of the vacuum or suction source, the characteristics (e.g., diameter, length, smoothness, etc.) of the various conduits or channels 168A, 150, 120, 180, 190 through which the waste materials are conveyed, the viscosity, density and other fluid properties of the waste materials and/or the like.
With continued reference to
In other embodiments, however, the contents of a container 200′ are transferred to the tip 160′ using one or more other methods or devices, either in addition to or in lieu of the methods discussed herein with reference to
In any of the embodiments of a handpiece assembly disclosed herein, including but not limited to those illustrated and discussed with reference to
Further, the serums, other fluids and/or other materials can be delivered to the tip 160 (e.g., from a cartridge, an external source, etc.) through one or more peripheral or other non-centrally located channels, conduits and/or other lines or fittings. For instance, in the handpiece assembly 100 illustrated in
Accordingly, in any of the embodiments disclosed herein, water (e.g., distilled, tap water, sterile, filtered, etc.), saline, serums, growth factors, other dilutants, other solutions, mixtures or fluids and/or the like can be delivered to the tip through one or more centrally and/or non-centrally located (e.g., peripheral, offset, etc.) openings. Thus, the flow pattern of such fluids and/or other materials across the tip (e.g., from the tip inlet to the tip outlet) can be advantageously controlled as desired or required for a particular application or use. For instance, in some embodiments, it may be desirable to introduce fluids and/or other materials through one, two or more peripheral or non-centrally located openings (e.g., 572A, 572B) of a tip (e.g., 560 of
In
Such configurations in which the distal end of a handpiece assembly comprises a nozzle, fitting or other protruding member that is adapted to be secured within a corresponding recess, other feature or other area of the tip can be incorporated into any of the handpiece assembly and/or tip embodiments disclosed herein, or variations thereof. As discussed in greater detail herein, such a nozzle-recess connection can be configured to place the tip in fluid communication with either a suction source or a fluid delivery source, as desired or required. One or more additional openings, conduits, channels and/or other hydraulic components in the tip and/or the handpiece assembly can be configured to transfer fluids and/or materials to and/or from the tip.
With reference to the cross-sectional view of
For any embodiments of a cartridge, vial or other container disclosed herein, the septum 314, membrane or other surface configured to be pierced, punctured or otherwise compromised can be re-sealable. In other words, such a septum 314 can be adapted to re-seal the internal contents of the cartridge 300 when the cartridge is removed from the handpiece assembly. Therefore, leakage of serums, other fluids and/or other materials contained within a cartridge can be reduced or prevented. In addition, the septum 314 can help ensure against contamination of the internal contents by preventing one or more materials from entering the cartridge.
As discussed, cartridges configured to be secured within a handpiece assembly can include any combination of serums, human growth factors, cytokines, collagen, brightening or lightening agents, peptides, peeling agents, acids, antioxidants, matrix proteins, saline, water (e.g., distilled, tap water, filtered, etc.) and/or other liquids or substances, as desired or required by a particular application or use. In certain embodiments, a treatment protocol may require the use of one, two or more different cartridges for a specific procedure. Thus, cartridges can be removed from or inserted into a handpiece assembly prior to or during a particular procedure.
Another embodiment of a cartridge 400 that is sized, shaped and otherwise configured for placement within a handpiece assembly is illustrated in
With continued reference to
A cartridge 400, such as the one illustrated in
According to certain arrangements, a cartridge 400 includes one or more solids, granular materials, gels, concentrated fluids and/or other substances that are adapted to dissolve, dilute, soften or otherwise mix when contacted by water, saline, other dilutants or dissolvents and/or other fluids. Thus, such materials or other substances can be placed within the cartridge 400 in one or more forms, such as, for example, as powder, granular material, a tablet, a capsule, a pill, other dissolvable solid, a concentrated solution, a gel and/or the like. In other embodiments, such solids, gels and/or other materials can be situated on the tip or other portion of the system (e.g., within a post or recess, adhered to one or more other exposed or hidden surfaces, within a removable cartridge upstream of the handpiece assembly as illustrated, for example, in
As discussed, in any of the embodiments of the cartridge (e.g., vial, ampoule, other standard or non-standard container, etc.) disclosed herein, the cartridge can be configured to releasably lock or otherwise secure to one or more portions of a handpiece assembly (e.g., recess). In other embodiments, a cartridge includes threads, tabs, slots and/or other features that are configured to engage corresponding portions of the handpiece assembly. In alternative arrangements, the cartridge is adapted to remain within a receiving portion of the handpiece assembly by friction or some other mechanism or feature, as desired or required.
According to certain embodiments, as illustrated in
According to certain embodiments, one or more of the fluid lines fluid lines 450, 462, 464, 466, 468 of the system schematically illustrated in
With reference back to the exploded perspective view of
In the embodiment illustrated in
As illustrated in
With continued reference to
As illustrated in
Moreover, the location, spacing, orientation, layout and/or other characteristics of the posts 574, 576, 578 or other protruding members can be different than illustrated or discussed herein, as desired or required by a particular procedure or application. As discussed, the lip member 567 of the tip 560 can help create an enclosed space 590 (or a plurality of spaces 590) generally defined between the distal end 561 of the tip 560 and the skin surface being treated. Therefore, according to some embodiments, the lip member 567 extends above the top of the protruding members 574, 576, 578 so that the protruding members are within the enclosed space during a treatment procedure. In other embodiments, however, the top surface of the lip 567 is below or generally aligned with the top surface of the protruding members 574, 576, 578.
With continued reference to
As illustrated in
Moreover, the distal end 561 of the tip 560 can include one or more outlet openings 572A, 572B through which exfoliated skin, spent serums, other waste liquids, fluids and other materials and/or the like can be removed. In the embodiment illustrated in
In some embodiments, the outlet openings 572A, 572B and/or the protruding members 574, 576, 578 are in fluid communication with outlet stems (not shown) that extend toward one or more collection areas 552 within an interior portion of the tip 560. Once within an interior cavity or other portion of the tip 560, such waste materials can be drawn into one or more removal or waste channels 120, 150 positioned within the handpiece assembly 100 (
As discussed herein with reference to the schematic of
For any of the tip embodiments disclosed herein, including those discussed with reference to
Another embodiment of a removable tip 660 is illustrated in
With further reference to
With continued reference to
In the depicted arrangement, since they are not in fluid communication with a vacuum or other suction force, some or all of the protruding members 674, 676 are not hollow and/or do not include openings therethrough. In other embodiments, however, one, some or all of the protruding members 674, 676 are configured to be in fluid communication with a collection area 652 of the tip 660. As illustrated in
Tips comprising removable pads 780A-780D or other abrasive members can help enhance the flexibility of a skin treatment device or system. For instance, such pads can allow a user to make changes to the skin treatment properties of a tip without having to replace the entire tip or changing the tip design. For example, a user can selectively change the roughness and/or abrasiveness of the tip by replacing only the pads 780A-780D along the distal end 761.
With continued reference to
As with other tip arrangements discussed and/or illustrated herein, the tip 760 depicted in
With continued reference to
As discussed, any of the tip embodiments disclosed herein, including but not limited to those illustrated in
Further, the connection and/or other hydraulic details of the tip and adjacent portions of the handpiece assembly can vary, as desired or required. For example, as discussed with reference to the embodiment of
Although only certain embodiments of tips are illustrated and discussed herein, any other tip configurations or designs can be used on a handpiece assembly to perform a skin treatment procedure. As discussed, in some embodiments, the tips are removable, allowing a user to selectively interchange tips either during a procedure or between procedures, as desired or required by a particular application. In other arrangements, tips are more permanently or semi-permanently attached to the handpiece assembly. Additional embodiments of tips are disclosed in U.S. patent application Ser. No. 11/392,348, filed on Mar. 29, 2006 and published on Jul. 5, 2007 as U.S. Publication No. 2007/0156124, and U.S. patent application Ser. No. 09/699,220, filed on Oct. 27, 2000 and issued on Oct. 7, 2003 as U.S. Pat. No. 6,629,983, the entireties of both of which are hereby incorporated by reference herein.
In any of the embodiments disclosed herein, or variations thereof, the tip, the handpiece assembly and/or any other component or device can include rigid and/or semi-rigid materials. For example, a tip can comprise plastic, another polymeric material, rubber, metal and/or the like. Accordingly, the tips and/or other portions of the handpiece assembly can be manufactured using any suitable method, such as, for example, injection or compression molding, thermoforming, other molding methods, casting and/or the like. The tips can be disposable so that they are used once or only for a limited number of times. Alternatively, if properly treated, the tips can be reused. Therefore, in such embodiments, the tips are preferably configured to withstand the required cleaning, sterilizing, disinfecting and/or other treatment procedures to which they may be exposed.
Any of the tips disclosed herein can be used in wet and/or dry systems. In general, wet systems include skin treatment devices, assemblies or systems in which serums, water, other fluids and/or other materials are conveyed, either continuously or intermittently, to the tip during a procedure. As discussed in greater detail herein, such fluids and/or other materials can be delivered through the handpiece assembly, tip and/or other components of the skin treatment system in their final, usable form. In other arrangements, such materials and/or substances are positioned on the tip and/or other portions the system (e.g., as solids, gels, concentrated solutions, etc.) and are adapted to be dissolved, diluted, mixed or otherwise combined with water (e.g., distilled, tap water, sterile, filtered, etc.), saline, other dilutants or dissolvents and/or other fluids to prepare them for use. On the other hand, dry systems can include skin treatment devices, assemblies and systems in which fluids and/or other materials are generally not conveyed to the tip during the procedure.
As discussed, one or more fluids and/or other substances can be delivered to the tip of a handpiece assembly during a skin treatment procedure. In some embodiments, such fluids and/or other materials are stored within a cartridge (e.g., vial, ampoule, other container, etc.) that is secured to or within the handpiece assembly. Alternatively, these fluids and/or other materials can be stored in a canister or other container that is separate from the handpiece assembly. In such arrangements, as discussed herein with reference to
In some embodiments, human growth factors, cytokines, soluble collagen, antioxidants, matrix proteins, serums, water (e.g., distilled, tap water, filtered, etc.), saline, other dilutants or dissolvents, vitamins, chemical exfoliation agents, lotions, soothing agents, brightening or lightening agents, peptides, peeling agents, acids, anesthetics, medicants, other non-active or active compounds, other fluids or materials, combination or mixtures thereof and/or any other substance are selectively delivered to the skin during a treatment procedure. Such materials can be delivered individually or as part of a mixture. Such materials or combination of materials can be provided in a cartridge or other container, which, as discussed, can be placed in fluid communication with a handpiece assembly. These treatment fluids and other materials, either alone or in combination, can help reduce the appearance of wrinkles, fine lines, age spots, scarring and/or other skin conditions. In addition, such fluids and/or other materials can help to reduce skin roughness, thereby facilitating rejuvenation of the skin and/or improving skin texture. Further, such fluids or other treatment materials can provide one or more other therapeutic, comfort, anesthetic, aesthetic or other benefits to a user or his or her skin.
In any of the embodiments described and/or illustrated herein, or variations thereof, treatment fluids and/or other materials can be delivered to the tip of a handpiece assembly using one or more devices or methods. For example, in some embodiments, such substances are selectively delivered through a cartridge, supply canister, fluid bottle, combinations thereof and/or the like. Such serums, compositions, other fluids and/or other materials or substances can be pre-mixed so that they are delivered to the tip and the skin unmodified or substantially unmodified.
As discussed in greater detail herein, in some embodiments, human growth factors, cytokines, soluble collagen, antioxidants, matrix proteins, serums, water (e.g., distilled, tap water, filtered, etc.), saline, other dilutants or dissolvents, vitamins, chemical exfoliation agents, lotions, soothing agents, brightening or lightening agents, peptides, peeling agents, acids, anesthetics, medicants, other non-active or active compounds, other fluids or materials, combination or mixtures thereof and/or any other substance are provided to users as a pack or in other forms. For example, such materials and other substances can be provided as a solid (e.g., tablet, capsule, etc.), dry granular materials, viscous gels, concentrated fluids or other solutions and/or the like. Such packs or other solids, semi-solid, gelatinous and/or other substances can be configured to be combined or mixed with water, saline and/or some other fluid by a user to achieve a desired end product or concentration.
In other embodiments, one or more treatment materials can be impregnated, embedded, deposited or otherwise positioned within and/or on the tips and any other portion of a handpiece assembly. Thus, such materials (e.g., powders, tablets, capsules, other solids, granular materials, gels, etc.) can advantageously dissolve, melt, break down or otherwise transform when they are contacted by water, saline, other dilutants, dissolvents and/or other liquids or fluids delivered to the tip (e.g., through the handpiece assembly, by an external fluid source, etc.) In other arrangements, the treatment materials are contained within a capsule, tablet or other enclosure. Such enclosures can be configured to dissolve when placed in water or some other fluid. Therefore, a user may be required to place a capsule, the contents of a pack or some other materials into a cartridge, canister or other container and add or otherwise supply water, saline, other fluids and/or other dissolvent before use.
With continued reference to
According to some embodiments, some or all of the posts 1174, 1776 or other protruding members comprise one or more materials or other substances D. For example, the posts can be at least partially filled with dried or granular materials, tablets, capsules, powders, gels, concentrated liquids and/or other substances that are configured to dissolve, melt, soften, dilute, disperse, mix or otherwise be removed from an interior of the protruding members 1174, 1176. Such materials or other substances, which can be provided in one or more different forms or phases (e.g., liquid, solid, gel, etc.), can include, without limitation, human growth factors, cytokines, collagen, antioxidants, matrix proteins, serums, vitamins, chemical exfoliation agents, lotions, soothing agents, brightening or lightening agents (e.g., kojic acid), peptides, peeling agents, acids, anesthetics, medicants, other non-active or active compounds, other fluids or materials, combination or mixtures thereof and/or the like.
With continued reference to
Providing the desired materials and/or other substances on the tip can help simplify a microdermabrasion or other skin treatment procedure. For instance, in such embodiments, the user may only need to provide water, saline and/or some other basic fluid to perform the procedure. Thus, the need to deliver separate serums, other fluids and/or materials through the handpiece assembly (e.g., using a manifold system, a cartridge, etc.) can be advantageously eliminated or simplified. As a result, the likelihood of a user making mistakes can be reduced or eliminated. In addition, by delivering only water, saline and/or other relatively clean fluids through the various delivery conduits, passages, ports, openings and other hydraulic components of the tip, handpiece assembly and other components of a skin treatment system, the need to periodically clean the various devices and other equipment can be advantageously reduced or eliminated. Thus, the effective life of the skin treatment system can be extended. Relatedly, the likelihood of potentially dangerous or undesirable cross-contamination between the various serums, agents, other fluids and/or other materials can also be reduced or eliminated.
With reference to the cross-sectional view of
The quantity, size, depth, shape, capacity, location, spacing and/or other details of the recesses or other openings positioned along one or more tip surfaces can vary, as desired or required. For example, in the tip arrangement of
In alternative embodiments, the desired solids D, other dry or semi-dry materials, gels, concentrated materials and/or other substances are included within a cartridge or other container. As illustrated in
With continued reference to
As illustrated in
With continued reference to
According to some embodiments, the disc 1390 includes a center opening 1394 to permit the disc 1390 to be positioned over a stem 1364 extending within an interior of the tip 1360. In the illustrated arrangement, the stem 1364 comprises an outlet conduit or channel that is configured to remove exfoliated skin, spent treatment materials and other debris away from the distal end of the tip 1360. However, as discussed herein with reference to the tip of
With continued reference to
Once the disc 1390, capsule or other member has been properly secured to the tip 1360, as depicted in
According to some embodiments, water, saline or other fluids are configured to flow past the exterior surfaces of the disc 1390, capsule or other item. Thus, solids, gels, fluids and/or other materials impregnated on such surfaces, positioned within recesses or other openings in fluid communication with such surfaces and/or the like can be transferred to the skin surface being treated. In alternative embodiments, the solids, gels, fluids and/or other materials are positioned within an interior cavity of the disc 1390 or other item. For example, the disc 1390 or capsule can comprise a cage or other porous structure that is configured to house one or more dissolvable or dilutable solids or gels. Therefore, water, saline and/or other fluids can be adapted to travel through one or more openings of the disc 1390 or other member in order to contact the various materials contained therein. Accordingly, the disc 1390 can be configured to lose mass over time as water or other fluids dissolve, dilute or otherwise combine with the materials positioned on or within the disc 1390. In alternative embodiments, the disc 1390 (e.g., cage, container having one or more openings, etc.) or other item secured within the tip 1360 is adapted to maintain its shape over time if such a disc is used to merely contain the solids, gels, fluids and/or other materials that will be selectively transported toward the distal end of the tip 1360.
Such discs 1390, capsules, containers or other items can be used in conjunction with any of the tip designs illustrated or discussed herein, or variations thereof. Further, the size, shape, general configuration, location relative to the tip or other adjacent portions of the handpiece assembly and/or any other characteristics of the disc 1390 can vary, as desired or required. For instance, the disc 1390 can include a non-circular shape (e.g., rectangular, triangular, other polygonal, elliptical, etc.). Further, the disc 1390 can include a curved or fluted surface. In other arrangements, a disc 1390 does not extend completely around a stem 1464 or other central portion of the tip interior. Thus, the disc 1390 can be asymmetrically positioned relative to the stem 1464 or tip centerline. In another embodiment, the disc 1390 is positioned on only one side of the stem 1464.
Another embodiment of a disc 1490 that is configured to be secured to a tip 1460 of a handpiece assembly is illustrated in
With continued reference to
The final products being delivered to the skin can include, without limitation, human growth factors, cytokines, soluble collagen, antioxidants, matrix proteins, serums, water (e.g., distilled, tap water, filtered, etc.), saline, other dilutants or dissolvents, vitamins, chemical exfoliation agents, lotions, soothing agents, brightening or lightening agents, peptides, peeling agents, acids, anesthetics, medicants, other non-active or active compounds, other fluids or materials, combination or mixtures thereof and/or any other substance. Alternatively, such solids, gels and/or other materials can be impregnated or otherwise positioned along one or more exterior surfaces of the disc 1490 (e.g., along the inner diameter of the opening 1494). As discussed with reference to other embodiments disclosed herein, the disc 1490 can be partially or completely formed from such dissolvable or removable materials, so that it loses mass over time (e.g., as water or other liquids come in contact with it). In other embodiments, the disc 1490 comprises a porous container (e.g., cage) that is configured to house one or more solids, gels and/or other materials therein. In such arrangements, the disc 1490 can be removed, refilled, replaced and/or reused, as desired or required.
In
With reference to the schematic of
Alternatively, water (e.g., tap, filtered, sterile, distilled, etc.), saline, other dilutants or dissolvents and/or other fluids can be stored within one or more of the containers 1710, 1720 located upstream of the handpiece assembly 1700. As discussed, such liquids and other fluids can be selectively delivered to the handpiece assembly 1700 in order to dissolve, dilute and/or mix with solids, gels, concentrated fluids, other materials and/or the like that are impregnated, deposited, stored or otherwise situated on or near the tip 1760.
In other embodiments, one or more of the upstream containers (e.g., container 1710 in
The schematic of
According to certain embodiments, the fluids and/or other materials included in the cartridge 1840A are in their final, ready-to-use state. Thus, the contents of a cartridge 1840A can be directly delivered to the tip 1860A (e.g., as a result of a suction force imparted on the delivery line 1802A) without being diluted, dissolved or mixed with any other fluid or substance. Alternatively, a cartridge 1840A can comprise solids, granulated materials, gels, concentrated solutions and/or the like that are adapted to be combined with one or more fluids, other dissolvents or dilutants and/or other fluids (e.g., water, saline, etc.). For instance, such fluids can be conveyed from the upstream delivery line and combined with the internal contents of a cartridge 1840A or other container when such a cartridge 1840 is properly positioned within a holder 1830A.
The embodiment illustrated in
With continued reference to
As illustrated in the cross-sectional view of
In some embodiments, as illustrated in
According to some embodiments, as shown in
In some embodiments, a procedure may be enhanced by providing one or more treatment fluids, serums and/or other materials to the skin surface being treated. For example, as discussed in greater detail herein, it may desirable to selectively provide human growth factors, cytokines, soluble collagen, antioxidants, matrix proteins, serums, water (e.g., distilled, tap water, filtered, etc.), saline, other dilutants or dissolvents, vitamins, chemical exfoliation agents, lotions, soothing agents, anesthetics, medicants, other non-active or active compounds, other fluids or materials, combination or mixtures thereof and/or any other substance to the tip 1960 of the handpiece assembly 1900. As discussed, such fluids and/or other materials can be delivered to the tip 1960 using one or more delivery conduits, passages and other hydraulic components of the handpiece assembly 1900.
However, in embodiments which do not include such passages, such as the one illustrated in
In order to adequately maintain the desired treatment fluids and/or other materials within the pads 1990, the pads 1990 can be included in an enclosed pouch or other sealed container. This will help ensure that the desired materials remain within and/or on the pad 1990 until such pads 1990 are inserted into a handpiece assembly 1900. In other embodiments, the pads include one or more solids, granular materials, gels, concentrated fluids and/or other substances that are configured to be contacted with water, saline, other dilutants or dissolvents and/or other fluids in order to convert them into a usable treatment material or mixture. Thus, an external fluid source can be used with the handpiece assembly 1900 of
The handpiece assembly 2000 illustrated in
Another embodiment of a handpiece assembly 2100 is illustrated in
With continued reference to
Alternatively, the delivery conduit 2140 can be configured to transfer only water, saline, other dilutants or dissolvents and/or other relatively clean fluids (e.g., fluids that have no solids or a low concentration of solids). In such configurations, as discussed in greater detail herein with reference to other arrangements, solids, semi-solids, granular materials, gels, concentrated solutions and/or other materials configured to be combined with the water, saline or other fluids being conveyed through the delivery conduits 2140 can be positioned within or near the delivery zone 2182. Thus, once water, saline and/or other fluids contact such materials, the desired or required treatment materials can be produced in the delivery zone 2182 and brought to the skin surface being exfoliated.
With further reference to
In any of the embodiments of a handpiece assembly disclosed herein, or equivalent thereof, one or more of the various treatment materials and/or other substances being conveyed to the skin surface can be selectively heated. Heating of fluids and/or other material streams to a desired temperature can help enhance one or more aspects of a skin treatment procedure. For example, in some arrangements, heated fluids and/or other materials are generally better absorbed into a skin surface, as the skin pores may be caused to open because of the elevated temperature. In other embodiments, heated fluids and other materials advantageously stimulate improved blood circulation along the skin surface (e.g., dermis). Further, heating of water, saline and/or other dilutants or dissolvents can help improve the manner in which solids, granulated materials, gels, concentrated fluids and/or other materials impregnated or otherwise positioned on a handpiece assembly dissolve, dilute and/or otherwise transform into the desired final product.
According to some embodiments, one or more heating devices or mechanisms are positioned within or on a handpiece assembly (e.g., the main body portion, the adjustable distal portion, the tip, etc.). In other configurations, heaters are positioned upstream of the handpiece assembly, such as, for example, on or within a cartridge or other container, a cartridge holder, fluid delivery lines and/or the like.
Fluid and/or other material streams being conveyed through a handpiece assembly can be heated conductively or convectively, as desired or required. Adequate heating devices or systems can include resistive heaters, other electrical heaters and/or the like. In other embodiments, heated air or other fluids can be used to thermally transfer heat to fluids and/or other materials being delivered through a handpiece assembly. In addition, such heaters can include one or more sensors, feedback loops, controllers and/or other components to help maintain the treatment materials being delivered to the skin surface at or near a desired temperature or within a desired range.
In some embodiments, one or more serums, other fluids and/or substances can be selectively delivered to or near a treatment surface of a handpiece assembly to help remedy a particular skin condition. For example, the system can be used to treat acne, dry or oily skin, fine lines, sun-damaged skin, other skin diseases or disorders and/or like. Further, the serums, other fluids, other materials and/or mixtures thereof can be customized to target a particular disorder, ailment, other treatable or chronic condition, skin type and/or the like.
In another embodiment, serums, medicants, other fluids, other materials, combinations thereof and/or the like are used during a follow-up step or procedure (e.g., secondary, tertiary, polishing, etc.) or post-treatment phase. For example, such materials and/or mixtures can be used to hydrate the skin and/or lighten treat skin damage, either in lieu of or in addition to exfoliating skin. In any such embodiments, the serums or other fluids or materials can comprise human growth factors, cytokines, soluble collagen, matrix proteins, other proteins, anti-oxidants, hyaluronic acid, medicants and/or the like.
According to certain configurations, the serums, other fluids, other materials and/or mixtures thereof are used to target acne, oily skin, dry skin, other skin types and/or other skin conditions, diseases or ailments. Further, a particular treatment procedure can utilize one, two or more of such serums, medicants and/or other fluids, materials or substances during various treatment phases (e.g., exfoliation, finish or polishing treatment, post-treatment, etc.).
One or more kits developed to target a specific type of user, skin condition, disease or ailment, desired result and/or the like can be provided to a user. For example, such a kit can comprise serums, medicants, other fluids, other materials, mixtures thereof and/or the like that target teenage acne. As discussed, the serums and/or other materials contained in such kits can be in one or more different forms, such as, for example, liquids, gels, other fluids, powders, dissolvable tablets or other packs, solids and/or the like. In some embodiments, such serums and/or other materials are configured for immediate use (e.g., by not requiring any dilution, premixing or other preparatory steps by a user). Alternatively, a particular amount of water, saline or other liquids, other dilution or dissolving agents and/or the like may need to be added to achieve a usable product. Kits can include one or more cartridges or other containers that are configured to be placed onto and removed from a handpiece assembly as discussed herein.
In addition, depending on who the target user is (e.g., teenagers, adults, etc.) and/or how severe a particular condition is, the concentration or strength of the serums, medicants, other fluids or materials, mixtures thereof and/or the like can be selectively varied. For example, for younger users, a kit directed at acne treatment can comprise lower concentrations of serums and/or other materials. According to another example, kits comprising higher concentrations or strengths of serums, medicants and/or other substances can be used to treat oily skin or acne in adults. In other arrangements, a kit targets users whose skin is generally normal or typical (e.g., the users' skin is not abnormally dry or oily, the users do not have excessive amount of acne or scarring, etc.).
As discussed, the kits can comprise one, two or more different types of medicants, other active or non-active agents, serums, other fluids, other materials, mixtures thereof and/or the like, as desired or required. For example, a kit can comprise a first combination of serum(s) and/or other material(s) that is intended to be used during a basic skin exfoliation procedure. Further, a kit may include a second treatment combination that is used in a follow-up treatment to treat oily skin, dry skin, another skin type, a skin disease or ailment, another skin condition and/or the like. However, a kit may comprise more or fewer treatment combinations, as desired or required by a particular skin treatment procedure.
The systems, apparatuses, devices and/or other articles disclosed herein may be formed through any suitable means. The various methods and techniques described above provide a number of ways to carry out the invention. Of course, it is to be understood that not necessarily all objectives or advantages described may be achieved in accordance with any particular embodiment described herein. Thus, for example, those skilled in the art will recognize that the methods may be performed in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other objectives or advantages as may be taught or suggested herein.
Furthermore, the skilled artisan will recognize the interchangeability of various features from different embodiments disclosed herein. Similarly, the various features and steps discussed above, as well as other known equivalents for each such feature or step, can be mixed and matched by one of ordinary skill in this art to perform methods in accordance with principles described herein. Additionally, the methods which are described and illustrated herein are not limited to the exact sequence of acts described, nor are they necessarily limited to the practice of all of the acts set forth. Other sequences of events or acts, or less than all of the events, or simultaneous occurrence of the events, may be utilized in practicing the embodiments of the invention.
Although the invention has been disclosed in the context of certain embodiments and examples, it will be understood by those skilled in the art that the invention extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses and obvious modifications and equivalents thereof. Accordingly, it is not intended that the invention be limited, except as by the appended claims.
This application is a continuation application of U.S. patent application Ser. No. 17/332,897, filed May 27, 2021, which is a continuation application of U.S. patent application Ser. No. 14/734,995, filed Jun. 9, 2015 and issued as U.S. Pat. No. 11,020,577 on Jun. 1, 2021, which is a continuation application of U.S. patent application Ser. No. 12/362,353, filed Jan. 29, 2009 and issued as U.S. Pat. No. 9,056,193 on Jun. 16, 2015, which claims the priority benefit under 35 U.S.C. § 119(e) of U.S. Provisional Application No. 61/024,504, filed Jan. 29, 2008, the entireties of all of which are hereby incorporated by reference as if fully set forth herein.
| Number | Name | Date | Kind |
|---|---|---|---|
| 1651585 | Clair | Dec 1927 | A |
| D117295 | Smith | Oct 1939 | S |
| D151807 | Berkowitz | Nov 1948 | S |
| 2608032 | Garver | Aug 1952 | A |
| 2631583 | Lavergne | Mar 1953 | A |
| 2701559 | Cooper | Feb 1955 | A |
| 2712823 | Kurtin | Jul 1955 | A |
| 2867214 | Wilson | Jan 1959 | A |
| 2881763 | Robbins | Apr 1959 | A |
| 2921585 | Schumann | Jan 1960 | A |
| 3037509 | Schutz | Jun 1962 | A |
| 3085573 | Meyer et al. | Apr 1963 | A |
| 3214869 | Stryker | Nov 1965 | A |
| 3468079 | Kaufman | Sep 1969 | A |
| 3476112 | Elstein | Nov 1969 | A |
| 3481677 | Abrahamson | Dec 1969 | A |
| 3505993 | Lewes et al. | Apr 1970 | A |
| 3560100 | Spatz | Feb 1971 | A |
| 3574239 | Sollerud | Apr 1971 | A |
| 3608553 | Balamuth | Sep 1971 | A |
| 3715838 | Young et al. | Feb 1973 | A |
| 3865352 | Nelson et al. | Feb 1975 | A |
| 3866264 | Engquist | Feb 1975 | A |
| D237776 | Arassa et al. | Nov 1975 | S |
| D237863 | Peters et al. | Dec 1975 | S |
| 3930598 | Slagle | Jan 1976 | A |
| 3948265 | Ani | Apr 1976 | A |
| 3964212 | Karder | Jun 1976 | A |
| 3968789 | Simoncini | Jul 1976 | A |
| 3977084 | Sloan | Aug 1976 | A |
| 4121388 | Wilson | Oct 1978 | A |
| 4155721 | Fletcher | May 1979 | A |
| 4170821 | Booth | Oct 1979 | A |
| 4182329 | Smit et al. | Jan 1980 | A |
| 4203431 | Abura et al. | May 1980 | A |
| D255325 | Hoyt | Jun 1980 | S |
| 4216233 | Stein | Aug 1980 | A |
| 4225254 | Holberg et al. | Sep 1980 | A |
| D258348 | Hoyt | Feb 1981 | S |
| D259921 | Hartmann | Jul 1981 | S |
| D260176 | Boschetti et al. | Aug 1981 | S |
| 4289158 | Nehring | Sep 1981 | A |
| 4299219 | Norris, Jr. | Nov 1981 | A |
| 4342522 | Mackles | Aug 1982 | A |
| 4378804 | Cortese | Apr 1983 | A |
| 4500222 | Clading-Boel | Feb 1985 | A |
| 4560373 | Sugino et al. | Dec 1985 | A |
| D288293 | Arvans | Feb 1987 | S |
| 4646480 | Williams | Mar 1987 | A |
| 4646482 | Chitjian | Mar 1987 | A |
| 4655743 | Hyde | Apr 1987 | A |
| 4671412 | Gatten | Jun 1987 | A |
| 4676749 | Mabille | Jun 1987 | A |
| D290999 | Novak | Jul 1987 | S |
| 4706676 | Peck | Nov 1987 | A |
| 4718467 | Di Gianfilippo et al. | Jan 1988 | A |
| 4754756 | Shelanski | Jul 1988 | A |
| 4757814 | Wang et al. | Jul 1988 | A |
| 4764362 | Barchas | Aug 1988 | A |
| 4795421 | Blasius, Jr. et al. | Jan 1989 | A |
| 4811734 | McGurk-Burleson et al. | Mar 1989 | A |
| 4836192 | Abbate | Jun 1989 | A |
| 4866202 | Weil | Sep 1989 | A |
| 4875287 | Creasy et al. | Oct 1989 | A |
| 4886078 | Shiffman | Dec 1989 | A |
| 4887994 | Bedford | Dec 1989 | A |
| 4900316 | Yamamoto | Feb 1990 | A |
| 4917086 | Feltovich et al. | Apr 1990 | A |
| 4925450 | Imonti et al. | May 1990 | A |
| D308480 | Hoyt | Jun 1990 | S |
| 4940350 | Kim | Jul 1990 | A |
| 4957747 | Stiefel | Sep 1990 | A |
| 4990841 | Elder | Feb 1991 | A |
| 5006004 | Dirksing et al. | Apr 1991 | A |
| 5006339 | Bargery et al. | Apr 1991 | A |
| 5012797 | Clarke | May 1991 | A |
| D317719 | Hestehave et al. | Jun 1991 | S |
| 5035089 | Tillman et al. | Jul 1991 | A |
| 5037431 | Summers et al. | Aug 1991 | A |
| 5037432 | Molinari | Aug 1991 | A |
| 5054339 | Yacowitz | Oct 1991 | A |
| 5100412 | Rosso | Mar 1992 | A |
| 5100424 | Jang | Mar 1992 | A |
| 5119839 | Rudolph | Jun 1992 | A |
| 5122153 | Harrel | Jun 1992 | A |
| 5171215 | Flanagan | Dec 1992 | A |
| 5192269 | Poli et al. | Mar 1993 | A |
| 5207234 | Rosso | May 1993 | A |
| 5217455 | Tan | Jun 1993 | A |
| 5222956 | Waldron | Jun 1993 | A |
| 5242433 | Smith et al. | Sep 1993 | A |
| 5254109 | Smith et al. | Oct 1993 | A |
| 5290273 | Tan | Mar 1994 | A |
| 5368581 | Smith et al. | Nov 1994 | A |
| 5387215 | Fisher | Feb 1995 | A |
| 5391151 | Wilmot | Feb 1995 | A |
| 5417674 | Smith et al. | May 1995 | A |
| 5419772 | Teitz et al. | May 1995 | A |
| 5423803 | Tankovich et al. | Jun 1995 | A |
| 5437372 | Per-Lee | Aug 1995 | A |
| 5441490 | Svedman | Aug 1995 | A |
| 5460620 | Smith et al. | Oct 1995 | A |
| 5470323 | Smith et al. | Nov 1995 | A |
| 5484427 | Gibbons | Jan 1996 | A |
| 5490736 | Haber et al. | Feb 1996 | A |
| 5512044 | Duer | Apr 1996 | A |
| 5562642 | Smith et al. | Oct 1996 | A |
| 5562643 | Johnson | Oct 1996 | A |
| 5611687 | Wagner | Mar 1997 | A |
| 5612797 | Clarke | Mar 1997 | A |
| 5618275 | Bock | Apr 1997 | A |
| 5626631 | Eckhouse | May 1997 | A |
| 5658323 | Miller | Aug 1997 | A |
| 5658583 | Zhang et al. | Aug 1997 | A |
| 5674235 | Parisi | Oct 1997 | A |
| 5676643 | Cann et al. | Oct 1997 | A |
| 5676648 | Henley | Oct 1997 | A |
| 5683971 | Rose et al. | Nov 1997 | A |
| 5697920 | Gibbons | Dec 1997 | A |
| 5707383 | Bays | Jan 1998 | A |
| 5713785 | Nishio | Feb 1998 | A |
| 5735833 | Olson | Apr 1998 | A |
| 5755751 | Eckhouse | May 1998 | A |
| 5759185 | Grinberg | Jun 1998 | A |
| 5762640 | Kajiwara et al. | Jun 1998 | A |
| 5779519 | Oliver | Jul 1998 | A |
| 5800446 | Banuchi | Sep 1998 | A |
| 5807353 | Schmitz | Sep 1998 | A |
| 5810842 | Di Fiore et al. | Sep 1998 | A |
| 5813416 | Rudolph | Sep 1998 | A |
| 5817050 | Klein | Oct 1998 | A |
| 5817089 | Tankovich et al. | Oct 1998 | A |
| 5834510 | Yu et al. | Nov 1998 | A |
| 5846215 | Zygmont | Dec 1998 | A |
| 5848998 | Marasco, Jr. | Dec 1998 | A |
| 5857995 | Thomas et al. | Jan 1999 | A |
| 5861142 | Schick | Jan 1999 | A |
| 5873881 | McEwen et al. | Feb 1999 | A |
| 5879323 | Henley | Mar 1999 | A |
| 5879376 | Miller | Mar 1999 | A |
| 5882201 | Salem | Mar 1999 | A |
| 5885260 | Mehl, Sr. et al. | Mar 1999 | A |
| 5908401 | Henley | Jun 1999 | A |
| 5911223 | Weaver et al. | Jun 1999 | A |
| 5919152 | Zygmont | Jul 1999 | A |
| 5919479 | Zhang et al. | Jul 1999 | A |
| 5954730 | Bernabei | Sep 1999 | A |
| 5971999 | Naldoni | Oct 1999 | A |
| 5980555 | Barbut et al. | Nov 1999 | A |
| 6019749 | Fields et al. | Feb 2000 | A |
| 6023639 | Hakky et al. | Feb 2000 | A |
| 6024733 | Eggers et al. | Feb 2000 | A |
| 6027402 | Oliver | Feb 2000 | A |
| 6027495 | Miller | Feb 2000 | A |
| 6032071 | Binder | Feb 2000 | A |
| 6036684 | Tankovich et al. | Mar 2000 | A |
| 6039745 | Di Fiore et al. | Mar 2000 | A |
| 6042552 | Cornier | Mar 2000 | A |
| D425241 | Nishizawa et al. | May 2000 | S |
| 6074382 | Asah et al. | Jun 2000 | A |
| 6080165 | DeJacma | Jun 2000 | A |
| 6080166 | McEwen et al. | Jun 2000 | A |
| D428142 | Stromblad | Jul 2000 | S |
| 6090085 | Mehl, Sr. et al. | Jul 2000 | A |
| 6093021 | Rainey | Jul 2000 | A |
| 6113559 | Klopotek | Sep 2000 | A |
| 6120512 | Bernabei | Sep 2000 | A |
| 6129701 | Cimino | Oct 2000 | A |
| 6136008 | Becker et al. | Oct 2000 | A |
| 6139553 | Dotan | Oct 2000 | A |
| 6139554 | Karkar et al. | Oct 2000 | A |
| 6142155 | Rudolph | Nov 2000 | A |
| 6149634 | Bernabei | Nov 2000 | A |
| 6149644 | Xie | Nov 2000 | A |
| 6159226 | Kim | Dec 2000 | A |
| 6162218 | Elbrecht et al. | Dec 2000 | A |
| 6162232 | Shadduck | Dec 2000 | A |
| 6165059 | Park et al. | Dec 2000 | A |
| 6174325 | Eckhouse | Jan 2001 | B1 |
| 6176198 | Kao et al. | Jan 2001 | B1 |
| 6183451 | Mehl, Sr. et al. | Feb 2001 | B1 |
| 6183483 | Chang | Feb 2001 | B1 |
| 6190376 | Asah et al. | Feb 2001 | B1 |
| 6193589 | Khalaj | Feb 2001 | B1 |
| 6196982 | Ball | Mar 2001 | B1 |
| 6231593 | Meserol | May 2001 | B1 |
| 6235039 | Parkin et al. | May 2001 | B1 |
| 6238275 | Metcalf et al. | May 2001 | B1 |
| 6241739 | Waldron | Jun 2001 | B1 |
| 6245347 | Zhang et al. | Jun 2001 | B1 |
| 6264666 | Coleman et al. | Jul 2001 | B1 |
| 6269271 | Bernabei | Jul 2001 | B1 |
| 6277116 | Utely et al. | Aug 2001 | B1 |
| 6277128 | Muldner | Aug 2001 | B1 |
| 6280438 | Eckhouse et al. | Aug 2001 | B1 |
| 6283978 | Cheski et al. | Sep 2001 | B1 |
| 6284266 | Zhang et al. | Sep 2001 | B1 |
| 6299620 | Shadduck | Oct 2001 | B1 |
| 6306119 | Weber et al. | Oct 2001 | B1 |
| 6306147 | Bernabei et al. | Oct 2001 | B1 |
| 6322548 | Payne et al. | Nov 2001 | B1 |
| 6322568 | Bemnabel et al. | Nov 2001 | B1 |
| 6325381 | von Engelbrechten | Dec 2001 | B1 |
| 6325769 | Klopotek | Dec 2001 | B1 |
| 6332886 | Green et al. | Dec 2001 | B1 |
| 6334074 | Spertell | Dec 2001 | B1 |
| 6355054 | Neuberger | Mar 2002 | B1 |
| 6368333 | Bernabei et al. | Apr 2002 | B2 |
| 6383177 | Balle-Petersen et al. | May 2002 | B1 |
| 6387089 | Kreindel et al. | May 2002 | B1 |
| 6387103 | Shadduck | May 2002 | B2 |
| 6401289 | Herbert | Jun 2002 | B1 |
| 6409736 | Bernabei | Jun 2002 | B1 |
| 6410599 | Johnson | Jun 2002 | B1 |
| RE37796 | Henley | Jul 2002 | E |
| 6414032 | Johnson | Jul 2002 | B1 |
| 6420431 | Johnson | Jul 2002 | B1 |
| 6423078 | Bays et al. | Jul 2002 | B1 |
| 6423750 | Johnson | Jul 2002 | B1 |
| 6432113 | Parkin et al. | Aug 2002 | B1 |
| 6432114 | Rosso | Aug 2002 | B1 |
| 6458109 | Henley et al. | Oct 2002 | B1 |
| 6471712 | Burres | Oct 2002 | B2 |
| 6477410 | Henley et al. | Nov 2002 | B1 |
| 6482212 | Bernabei et al. | Nov 2002 | B1 |
| 6488646 | Zygmont | Dec 2002 | B1 |
| 6494856 | Zygmont | Dec 2002 | B1 |
| 6500183 | Waldron | Dec 2002 | B1 |
| 6503256 | Parkin et al. | Jan 2003 | B2 |
| 6508813 | Altshuler | Jan 2003 | B1 |
| 6511486 | Mercier et al. | Jan 2003 | B2 |
| 6514243 | Eckhouse et al. | Feb 2003 | B1 |
| 6514262 | Di Fiore et al. | Feb 2003 | B1 |
| 6514278 | Hibst et al. | Feb 2003 | B1 |
| 6518538 | Bernabei | Feb 2003 | B2 |
| 6520931 | Suh | Feb 2003 | B2 |
| D472136 | Hermann | Mar 2003 | S |
| 6527716 | Eppstein | Mar 2003 | B1 |
| 6527783 | Ignon | Mar 2003 | B1 |
| 6533776 | Asah et al. | Mar 2003 | B2 |
| 6535761 | Bernabei | Mar 2003 | B2 |
| 6537242 | Palmer | Mar 2003 | B1 |
| 6540757 | Hruska et al. | Apr 2003 | B1 |
| 6546281 | Zhang et al. | Apr 2003 | B1 |
| 6562013 | Marasco, Jr. | May 2003 | B1 |
| 6562050 | Owen | May 2003 | B1 |
| 6564093 | Ostrow et al. | May 2003 | B1 |
| 6565535 | Zaias et al. | May 2003 | B2 |
| 6569157 | Shain et al. | May 2003 | B1 |
| 6582442 | Simon et al. | Jun 2003 | B2 |
| 6587730 | Bernabei | Jul 2003 | B2 |
| 6589218 | Garcia | Jul 2003 | B2 |
| 6592595 | Mallett et al. | Jul 2003 | B1 |
| 6595934 | Hissong et al. | Jul 2003 | B1 |
| 6611706 | Avrahami et al. | Aug 2003 | B2 |
| 6626445 | Murphy et al. | Sep 2003 | B2 |
| 6629927 | Mesaros et al. | Oct 2003 | B1 |
| 6629971 | McDaniel | Oct 2003 | B2 |
| 6629974 | Penny et al. | Oct 2003 | B2 |
| 6629983 | Ignon | Oct 2003 | B1 |
| 6635035 | Marasco et al. | Oct 2003 | B1 |
| 6641591 | Shadduck | Nov 2003 | B1 |
| 6645184 | Zelickson et al. | Nov 2003 | B1 |
| 6652888 | Rhoades | Nov 2003 | B2 |
| 6666874 | Heitzmann et al. | Dec 2003 | B2 |
| 6673081 | Tavger et al. | Jan 2004 | B1 |
| 6673082 | Mallett et al. | Jan 2004 | B2 |
| D486915 | Warschewske et al. | Feb 2004 | S |
| 6685853 | Angelopoulos et al. | Feb 2004 | B1 |
| 6687537 | Bernabei | Feb 2004 | B2 |
| 6689380 | Marchitto et al. | Feb 2004 | B1 |
| 6695853 | Karasiuk | Feb 2004 | B2 |
| 6699237 | Weber et al. | Mar 2004 | B2 |
| 6712805 | Weimann | Mar 2004 | B2 |
| 6726673 | Zhang et al. | Apr 2004 | B1 |
| D490561 | Angeletta | May 2004 | S |
| 6735470 | Henley et al. | May 2004 | B2 |
| 6743211 | Prausnitz et al. | Jun 2004 | B1 |
| 6743215 | Bernabei | Jun 2004 | B2 |
| 6764493 | Weber et al. | Jul 2004 | B1 |
| 6780426 | Zhang et al. | Aug 2004 | B2 |
| D496101 | Davison | Sep 2004 | S |
| 6800083 | Hiblar et al. | Oct 2004 | B2 |
| 6800849 | Staats | Oct 2004 | B2 |
| D499207 | Angeletta | Nov 2004 | S |
| D499841 | Angeletta | Dec 2004 | S |
| D502288 | Longoria | Feb 2005 | S |
| D502289 | Longoria | Feb 2005 | S |
| D502569 | Longoria | Mar 2005 | S |
| 6869611 | Kligman et al. | Mar 2005 | B1 |
| 6878144 | Altshuler et al. | Apr 2005 | B2 |
| 6887260 | McDaniel | May 2005 | B1 |
| 6905487 | Zimmerman | Jun 2005 | B2 |
| 6911031 | Muldner | Jun 2005 | B2 |
| 6926681 | Ramey et al. | Aug 2005 | B1 |
| 6938805 | Brincat | Sep 2005 | B2 |
| 6942649 | Ignon et al. | Sep 2005 | B2 |
| 6960206 | Keane | Nov 2005 | B2 |
| 6980448 | Foss et al. | Dec 2005 | B2 |
| 7001355 | Nunomura et al. | Feb 2006 | B2 |
| 7004933 | McDaniel | Feb 2006 | B2 |
| D517699 | Lansohn | Mar 2006 | S |
| 7031805 | Lee et al. | Apr 2006 | B2 |
| 7044938 | La Bianco et al. | May 2006 | B2 |
| 7051907 | Brincat | May 2006 | B2 |
| 7052503 | Bernabei | May 2006 | B2 |
| D522360 | Caserta et al. | Jun 2006 | S |
| 7062317 | Avrahami et al. | Jun 2006 | B2 |
| 7069073 | Henley et al. | Jun 2006 | B2 |
| 7070488 | Suissa et al. | Jul 2006 | B2 |
| 7083580 | Bernabei | Aug 2006 | B2 |
| 7087036 | Busby et al. | Aug 2006 | B2 |
| 7087063 | Carson et al. | Aug 2006 | B2 |
| 7094252 | Koop | Aug 2006 | B2 |
| 7108689 | Eckhouse et al. | Sep 2006 | B2 |
| 7115275 | Clarot et al. | Oct 2006 | B2 |
| 7118563 | Weckwerth et al. | Oct 2006 | B2 |
| 7122029 | Koop et al. | Oct 2006 | B2 |
| 7135011 | Powers et al. | Nov 2006 | B2 |
| D533962 | Angeletta | Dec 2006 | S |
| 7153311 | Chung | Dec 2006 | B2 |
| 7166086 | Haider et al. | Jan 2007 | B2 |
| D536481 | Angeletta | Feb 2007 | S |
| 7172572 | Diamond et al. | Feb 2007 | B2 |
| 7189230 | Knowlton | Mar 2007 | B2 |
| 7197359 | Tokudome et al. | Mar 2007 | B1 |
| 7198623 | Fischer et al. | Apr 2007 | B2 |
| 7201765 | McDaniel | Apr 2007 | B2 |
| D545207 | De Baschmakoff | Jun 2007 | S |
| 7232431 | Weimann | Jun 2007 | B1 |
| 7232444 | Chang | Jun 2007 | B2 |
| 7241208 | Suissa et al. | Jul 2007 | B2 |
| 7250045 | Island et al. | Jul 2007 | B2 |
| D548341 | Ohta et al. | Aug 2007 | S |
| D548843 | Kertz | Aug 2007 | S |
| D553005 | Py et al. | Oct 2007 | S |
| 7276051 | Henley et al. | Oct 2007 | B1 |
| 7293930 | Chuang | Nov 2007 | B2 |
| D557611 | Ingemarsson | Dec 2007 | S |
| 7314326 | Rosenberg | Jan 2008 | B2 |
| 7316657 | Kleinhenz et al. | Jan 2008 | B2 |
| 7316671 | Lastovich et al. | Jan 2008 | B2 |
| 7318828 | Revivo | Jan 2008 | B1 |
| 7320691 | Pilcher et al. | Jan 2008 | B2 |
| 7320801 | Kelly | Jan 2008 | B2 |
| 7326199 | MacFarland et al. | Feb 2008 | B2 |
| 7329252 | Yamazaki et al. | Feb 2008 | B1 |
| 7354423 | Zelickson et al. | Apr 2008 | B2 |
| 7364565 | Freeman | Apr 2008 | B2 |
| D568473 | Ashiwa et al. | May 2008 | S |
| 7367981 | Bernaz | May 2008 | B2 |
| 7384405 | Rhoades | Jun 2008 | B2 |
| 7422567 | Lastovich et al. | Sep 2008 | B2 |
| 7427273 | Mitsui | Sep 2008 | B2 |
| 7440798 | Redding, Jr. | Oct 2008 | B2 |
| 7458944 | Liste et al. | Dec 2008 | B2 |
| D584151 | Murphy | Jan 2009 | S |
| 7476205 | Erdmann | Jan 2009 | B2 |
| 7477938 | Sun et al. | Jan 2009 | B2 |
| 7482314 | Grimes et al. | Jan 2009 | B2 |
| 7485125 | Sjostrom | Feb 2009 | B2 |
| 7489989 | Sukhanov et al. | Feb 2009 | B2 |
| 7494503 | McDaniel | Feb 2009 | B2 |
| 7507228 | Sun et al. | Mar 2009 | B2 |
| 7572238 | Rhoades | Aug 2009 | B2 |
| 7582067 | Van Acker | Sep 2009 | B2 |
| 7597900 | Zimmer et al. | Oct 2009 | B2 |
| 7597901 | Clarot et al. | Oct 2009 | B2 |
| 7607972 | Groman | Oct 2009 | B2 |
| 7658742 | Karasluk | Feb 2010 | B2 |
| 7678120 | Shadduck | Mar 2010 | B2 |
| 7730979 | Kahrig | Jun 2010 | B2 |
| 7731570 | Groman | Jun 2010 | B2 |
| 7740651 | Barak et al. | Jun 2010 | B2 |
| 7744582 | Sadowski et al. | Jun 2010 | B2 |
| 7749260 | Da Silva et al. | Jul 2010 | B2 |
| 7758537 | Brunell et al. | Jul 2010 | B1 |
| 7771374 | Slatkine | Aug 2010 | B2 |
| 7780652 | MacFarland et al. | Aug 2010 | B2 |
| 7789886 | Shadduck | Sep 2010 | B2 |
| D625198 | Hall | Oct 2010 | S |
| 7814915 | Davenport et al. | Oct 2010 | B2 |
| 7837695 | Hart et al. | Nov 2010 | B2 |
| 7857806 | Karpowicz et al. | Dec 2010 | B2 |
| 7862564 | Goble | Jan 2011 | B2 |
| 7901373 | Tavger | Mar 2011 | B2 |
| 7927188 | Groman | Apr 2011 | B2 |
| 7951156 | Karasluk | May 2011 | B2 |
| D639164 | Walsh | Jun 2011 | S |
| 7981111 | Grove et al. | Jul 2011 | B2 |
| 7981112 | Neev | Jul 2011 | B1 |
| 7993333 | Oral et al. | Aug 2011 | B2 |
| 8025669 | David et al. | Sep 2011 | B1 |
| RE42960 | Waldron | Nov 2011 | E |
| 8048064 | Hwang et al. | Nov 2011 | B2 |
| 8048089 | Ignon et al. | Nov 2011 | B2 |
| 8066716 | Shadduck | Nov 2011 | B2 |
| 8088085 | Thiebaut et al. | Jan 2012 | B2 |
| 8105295 | Blott et al. | Jan 2012 | B2 |
| 8128638 | Karasiuk et al. | Mar 2012 | B2 |
| 8135475 | Kreindel et al. | Mar 2012 | B2 |
| 8182473 | Altshuler et al. | May 2012 | B2 |
| D664254 | Yokoyama et al. | Jul 2012 | S |
| 8221437 | Waldron et al. | Jul 2012 | B2 |
| 8226663 | Remsburg et al. | Jul 2012 | B2 |
| 8231292 | Rabe et al. | Jul 2012 | B2 |
| 8236008 | Boone, III et al. | Aug 2012 | B2 |
| 8236036 | Frost | Aug 2012 | B1 |
| 8241094 | Groman | Aug 2012 | B2 |
| 8273080 | Mehta | Sep 2012 | B2 |
| 8276592 | Davenport et al. | Oct 2012 | B2 |
| 8277287 | Hart | Oct 2012 | B2 |
| 8282630 | Neev | Oct 2012 | B2 |
| 8313480 | Neev | Nov 2012 | B2 |
| 8317781 | Owens et al. | Nov 2012 | B2 |
| 8323253 | Hantash et al. | Dec 2012 | B2 |
| 8337513 | Shadduck | Dec 2012 | B2 |
| 8343116 | Ignon et al. | Jan 2013 | B2 |
| 8360826 | Groman | Jan 2013 | B2 |
| D676764 | Moore et al. | Feb 2013 | S |
| D678783 | Wilcox et al. | Mar 2013 | S |
| 8398621 | Beerwerth et al. | Mar 2013 | B2 |
| D680437 | Bartolo et al. | Apr 2013 | S |
| 8430104 | Hennings et al. | Apr 2013 | B2 |
| 8435234 | Chan et al. | May 2013 | B2 |
| 8475507 | Dewey et al. | Jul 2013 | B2 |
| 8478396 | Tsao et al. | Jul 2013 | B2 |
| 8480721 | Owens et al. | Jul 2013 | B2 |
| 8496654 | Adanny et al. | Jul 2013 | B2 |
| 8496695 | Kang et al. | Jul 2013 | B2 |
| 8535299 | Giovannoli | Sep 2013 | B2 |
| 8545419 | Kim | Oct 2013 | B2 |
| 8545489 | Giovannoli | Oct 2013 | B2 |
| 8551104 | Weckwerth et al. | Oct 2013 | B2 |
| 8562626 | Sabir et al. | Oct 2013 | B2 |
| 8573874 | Neuner | Nov 2013 | B2 |
| 8579916 | Cheney | Nov 2013 | B2 |
| 8597284 | Castro | Dec 2013 | B2 |
| D697404 | Johnson et al. | Jan 2014 | S |
| 8632378 | Groman | Jan 2014 | B2 |
| D699367 | Lee et al. | Feb 2014 | S |
| 8656931 | Davenport et al. | Feb 2014 | B2 |
| 8668552 | Groman | Mar 2014 | B2 |
| 8679039 | Tieu et al. | Mar 2014 | B2 |
| 8700176 | Azar et al. | Apr 2014 | B2 |
| 8702691 | Weber et al. | Apr 2014 | B2 |
| 8702771 | Frost | Apr 2014 | B1 |
| 8721662 | Karasluk | May 2014 | B2 |
| 8728064 | Schomacker et al. | May 2014 | B2 |
| 8740917 | Pilcher et al. | Jun 2014 | B2 |
| D709617 | Iliesco de Grimaldi et al. | Jul 2014 | S |
| 8814836 | Ignon et al. | Aug 2014 | B2 |
| 8818500 | Duquet et al. | Aug 2014 | B2 |
| 8821940 | Harris et al. | Sep 2014 | B2 |
| 8834933 | Harris et al. | Sep 2014 | B2 |
| 8858570 | Chang | Oct 2014 | B2 |
| 8939669 | Le et al. | Jan 2015 | B2 |
| D722172 | Amemiya et al. | Feb 2015 | S |
| 8945104 | Boone, III et al. | Feb 2015 | B2 |
| 8945109 | Mehta | Feb 2015 | B2 |
| 8974442 | Boss, Jr. | Mar 2015 | B1 |
| 9017391 | McDaniel | Apr 2015 | B2 |
| 9017392 | Owens et al. | Apr 2015 | B2 |
| 9044582 | Chang et al. | Jun 2015 | B2 |
| 9050133 | Boone, III et al. | Jun 2015 | B1 |
| 9050156 | Groman | Jun 2015 | B2 |
| 9056193 | Ignon et al. | Jun 2015 | B2 |
| D734154 | Johnson et al. | Jul 2015 | S |
| 9072521 | Levi et al. | Jul 2015 | B2 |
| 9072533 | Liu et al. | Jul 2015 | B2 |
| 9072892 | Owens et al. | Jul 2015 | B2 |
| 9084587 | Eckhouse et al. | Jul 2015 | B2 |
| 9149322 | Knowlton | Oct 2015 | B2 |
| D743269 | Pape | Nov 2015 | S |
| D743558 | Kim et al. | Nov 2015 | S |
| 9186490 | Chang et al. | Nov 2015 | B2 |
| 9227044 | Bansal et al. | Jan 2016 | B2 |
| 9227082 | McDaniel | Jan 2016 | B2 |
| 9233207 | Polyakov et al. | Jan 2016 | B2 |
| 9271755 | Luzon et al. | Mar 2016 | B2 |
| 9278230 | Levin et al. | Mar 2016 | B2 |
| 9283037 | Bragagna et al. | Mar 2016 | B2 |
| 9314302 | Dougal | Apr 2016 | B2 |
| 9351792 | Manstein et al. | May 2016 | B2 |
| 9351794 | Suckewer et al. | May 2016 | B2 |
| 9375281 | Moench et al. | Jun 2016 | B2 |
| 9421260 | Harris et al. | Aug 2016 | B2 |
| 9421261 | Harris et al. | Aug 2016 | B2 |
| D765512 | Joulia | Sep 2016 | S |
| 9439964 | Harris et al. | Sep 2016 | B2 |
| 9440093 | Homer | Sep 2016 | B2 |
| 9452013 | Manstein | Sep 2016 | B2 |
| 9468464 | Shadduck | Oct 2016 | B2 |
| 9474886 | Ignon et al. | Oct 2016 | B2 |
| D772481 | Paquet | Nov 2016 | S |
| 9480836 | Na | Nov 2016 | B2 |
| 9486615 | Ignon et al. | Nov 2016 | B2 |
| 9498610 | Ignon et al. | Nov 2016 | B2 |
| 9517085 | Karasluk | Dec 2016 | B2 |
| 9522287 | Owens et al. | Dec 2016 | B2 |
| 9550052 | Ignon et al. | Jan 2017 | B2 |
| 9566088 | Ignon et al. | Feb 2017 | B2 |
| 9566454 | Barthe et al. | Feb 2017 | B2 |
| 9572880 | Harris et al. | Feb 2017 | B2 |
| 9597527 | Buchholz et al. | Mar 2017 | B2 |
| 2782881 | Seiders et al. | Apr 2017 | A1 |
| D787054 | Rini et al. | May 2017 | S |
| 9636521 | Isserow et al. | May 2017 | B2 |
| 9636522 | Oversluizen et al. | May 2017 | B2 |
| 9642997 | Ignon et al. | May 2017 | B2 |
| 9662482 | Ignon et al. | May 2017 | B2 |
| 9669233 | Quisenberry et al. | Jun 2017 | B2 |
| 9675817 | Isserow et al. | Jun 2017 | B2 |
| 9694199 | Duquet et al. | Jul 2017 | B2 |
| 9700684 | Vlodaver et al. | Jul 2017 | B2 |
| 9731053 | Alal | Aug 2017 | B2 |
| 9744315 | Levi | Aug 2017 | B1 |
| 9775645 | Boone, III | Oct 2017 | B2 |
| 9775646 | Shadduck | Oct 2017 | B2 |
| 9775976 | Grez | Oct 2017 | B2 |
| 9814485 | Pratt et al. | Nov 2017 | B2 |
| 9814647 | Ajiki | Nov 2017 | B2 |
| 9814868 | Gnon et al. | Nov 2017 | B2 |
| 9814906 | McDaniel | Nov 2017 | B2 |
| 9833261 | Boone, III et al. | Dec 2017 | B2 |
| 9861442 | Tankovich et al. | Jan 2018 | B2 |
| D811225 | Newson | Feb 2018 | S |
| D811381 | Morohoshi et al. | Feb 2018 | S |
| 9918727 | Boone, III et al. | Mar 2018 | B1 |
| 9949552 | Rabe et al. | Apr 2018 | B2 |
| 9950147 | Mehta | Apr 2018 | B2 |
| 9955769 | Rabe et al. | May 2018 | B2 |
| 9962220 | Domankevitz | May 2018 | B2 |
| 9968800 | Anderson et al. | May 2018 | B2 |
| 10004919 | Lemmens et al. | Jun 2018 | B2 |
| D822845 | Shimobayashi et al. | Jul 2018 | S |
| 10010445 | Isserow et al. | Jul 2018 | B2 |
| 10022289 | Ajiki et al. | Jul 2018 | B2 |
| 10035007 | Ignon et al. | Jul 2018 | B2 |
| D825763 | Lim et al. | Aug 2018 | S |
| 10052467 | Bansal et al. | Aug 2018 | B2 |
| D829333 | Shin et al. | Sep 2018 | S |
| 10076354 | Knowlton | Sep 2018 | B2 |
| 10076646 | Casasanta, III et al. | Sep 2018 | B2 |
| 10080581 | Knowlton | Sep 2018 | B2 |
| D829921 | Xiong | Oct 2018 | S |
| 10092478 | Amit | Oct 2018 | B1 |
| 10105191 | Blanco et al. | Oct 2018 | B2 |
| D833283 | Rock | Nov 2018 | S |
| 10130390 | Hart et al. | Nov 2018 | B1 |
| 10130827 | Buchholz et al. | Nov 2018 | B2 |
| D836781 | Meurer et al. | Dec 2018 | S |
| 10149969 | Grez et al. | Dec 2018 | B2 |
| 10149984 | Modi et al. | Dec 2018 | B2 |
| 10172644 | Ignon et al. | Jan 2019 | B2 |
| 10179229 | Ignon et al. | Jan 2019 | B2 |
| 10183183 | Burdette | Jan 2019 | B2 |
| 10188193 | Rabe et al. | Jan 2019 | B2 |
| 10206743 | Tankovich et al. | Feb 2019 | B2 |
| 10207034 | Collins | Feb 2019 | B2 |
| 10220122 | Clark, III et al. | Mar 2019 | B2 |
| 10238812 | Ignon | Mar 2019 | B2 |
| 10238849 | Britva et al. | Mar 2019 | B2 |
| 10251675 | Ignon et al. | Apr 2019 | B2 |
| 10252044 | Bock | Apr 2019 | B2 |
| 10271900 | Marchitto et al. | Apr 2019 | B2 |
| 10272258 | Quisenberry et al. | Apr 2019 | B2 |
| D851759 | Jones et al. | Jun 2019 | S |
| 10307330 | Sedic | Jun 2019 | B1 |
| 10308378 | Goodwin et al. | Jun 2019 | B2 |
| 10314378 | Rabe et al. | Jun 2019 | B2 |
| 10321948 | Knowlton | Jun 2019 | B2 |
| 10328277 | Modi et al. | Jun 2019 | B2 |
| D852962 | Chang | Jul 2019 | S |
| 10335191 | Knowlton | Jul 2019 | B2 |
| 10357641 | Ignon et al. | Jul 2019 | B2 |
| 10357642 | Ignon et al. | Jul 2019 | B2 |
| 10334933 | Rosario et al. | Aug 2019 | B2 |
| 10369073 | Rosario et al. | Aug 2019 | B2 |
| 10413359 | Felsenstein et al. | Sep 2019 | B2 |
| D861913 | Stamm et al. | Oct 2019 | S |
| 10456197 | Felsenstein et al. | Oct 2019 | B2 |
| 10456321 | Shadduck | Oct 2019 | B2 |
| 10456567 | Streeter | Oct 2019 | B2 |
| D867587 | Holtz | Nov 2019 | S |
| 10463429 | Deem et al. | Nov 2019 | B2 |
| 10471274 | Liu et al. | Nov 2019 | B2 |
| 10485983 | Boone, III et al. | Nov 2019 | B1 |
| D868981 | Salamon et al. | Dec 2019 | S |
| D873430 | Accolla | Jan 2020 | S |
| D873481 | Larkin | Jan 2020 | S |
| 10524835 | Shadduck et al. | Jan 2020 | B2 |
| 10537304 | Barthe et al. | Jan 2020 | B2 |
| 10537640 | Harris et al. | Jan 2020 | B2 |
| 10556096 | Ignon et al. | Feb 2020 | B2 |
| 10556097 | Ignon et al. | Feb 2020 | B2 |
| 10583037 | Isserow et al. | Mar 2020 | B2 |
| D886370 | Soutelo Gomes | Jun 2020 | S |
| D886372 | Weinrich | Jun 2020 | S |
| D887571 | Liu | Jun 2020 | S |
| 10667985 | Decaux et al. | Jun 2020 | B2 |
| 10675481 | Tankovich | Jun 2020 | B1 |
| 10688290 | Yuval | Jun 2020 | B1 |
| 10702328 | Slatkine et al. | Jul 2020 | B2 |
| 10716924 | Knowlton | Jul 2020 | B2 |
| D893024 | Whiteside | Aug 2020 | S |
| 10736653 | Knowlton | Aug 2020 | B2 |
| 10737080 | Patterson | Aug 2020 | B2 |
| 10758261 | Richardson | Sep 2020 | B2 |
| 10772658 | Knowlton | Sep 2020 | B2 |
| 10792382 | Rafko | Oct 2020 | B2 |
| 10799285 | Mulholland | Oct 2020 | B2 |
| 10799430 | Danto | Oct 2020 | B2 |
| 10813694 | Johnson et al. | Oct 2020 | B2 |
| 10835287 | Shadduck et al. | Nov 2020 | B2 |
| 10835726 | Redding, Jr. | Nov 2020 | B2 |
| D903889 | Luo et al. | Dec 2020 | S |
| 10850095 | Ebbers et al. | Dec 2020 | B2 |
| 10856900 | Knowlton | Dec 2020 | B2 |
| 10860026 | Nguyen et al. | Dec 2020 | B2 |
| 10874579 | Rembert | Dec 2020 | B1 |
| D908282 | Kim | Jan 2021 | S |
| 10893907 | Kim | Jan 2021 | B2 |
| 10912428 | Daffer | Feb 2021 | B2 |
| 10918190 | Laudati | Feb 2021 | B2 |
| 10946191 | Cazares Delgadillo | Mar 2021 | B2 |
| 10952811 | Blanco et al. | Mar 2021 | B2 |
| 10952907 | Carver | Mar 2021 | B1 |
| D917290 | Bravman et al. | Apr 2021 | S |
| 10980592 | Horton et al. | Apr 2021 | B2 |
| 10993743 | Ignon et al. | May 2021 | B2 |
| 11020577 | Ignon et al. | Jun 2021 | B2 |
| 11045661 | Oversluizen et al. | Jun 2021 | B2 |
| D927008 | Rappaport | Aug 2021 | S |
| D928977 | Dijkstra | Aug 2021 | S |
| 11083515 | Slatkine et al. | Aug 2021 | B2 |
| 11123039 | Barthe et al. | Sep 2021 | B2 |
| 11141761 | Connelly et al. | Oct 2021 | B2 |
| 11154723 | Lee | Oct 2021 | B2 |
| 11172978 | Wootten et al. | Nov 2021 | B2 |
| 11202657 | Ignon et al. | Dec 2021 | B2 |
| 11213321 | Ignon et al. | Jan 2022 | B2 |
| 11224728 | Ignon et al. | Jan 2022 | B2 |
| 11241357 | Ignon et al. | Feb 2022 | B2 |
| 11247039 | Schwarz | Feb 2022 | B2 |
| 11278101 | Jeannin et al. | Mar 2022 | B2 |
| 11291474 | Nicolas et al. | Apr 2022 | B2 |
| 11291498 | Slatkine et al. | Apr 2022 | B2 |
| 11311721 | Ebbers et al. | Apr 2022 | B2 |
| 11337745 | Kim | May 2022 | B2 |
| 11337755 | Hancock et al. | May 2022 | B2 |
| 11351063 | Locke et al. | Jun 2022 | B2 |
| 11419678 | Deem et al. | Aug 2022 | B2 |
| D964581 | Guo | Sep 2022 | S |
| 11446477 | Ignon et al. | Sep 2022 | B2 |
| 11452852 | Quan et al. | Sep 2022 | B2 |
| 11497553 | Reinhard et al. | Nov 2022 | B2 |
| 11504148 | Friend | Nov 2022 | B2 |
| 11517350 | Ignon et al. | Dec 2022 | B2 |
| 11540882 | Masotti et al. | Jan 2023 | B2 |
| 11547840 | Ignon et al. | Jan 2023 | B2 |
| D979782 | Sung et al. | Feb 2023 | S |
| 11590345 | Danitz et al. | Feb 2023 | B2 |
| 11602629 | Schwarz et al. | Mar 2023 | B2 |
| 11612726 | Ignon et al. | Mar 2023 | B2 |
| 11717326 | Ignon et al. | Aug 2023 | B2 |
| 11744999 | Ignon et al. | Sep 2023 | B2 |
| 11806495 | Ignon et al. | Nov 2023 | B2 |
| 20010023351 | Eilers | Sep 2001 | A1 |
| 20010037118 | Shadduck | Nov 2001 | A1 |
| 20010049511 | Coleman et al. | Dec 2001 | A1 |
| 20020016601 | Shadduck | Feb 2002 | A1 |
| 20020040199 | Klopotek | Apr 2002 | A1 |
| 20020041891 | Cheski | Apr 2002 | A1 |
| 20020058952 | Weber et al. | May 2002 | A1 |
| 20020099356 | Unger et al. | Jul 2002 | A1 |
| 20020107527 | Burres | Aug 2002 | A1 |
| 20020128663 | Mercier et al. | Sep 2002 | A1 |
| 20020133110 | Citow | Sep 2002 | A1 |
| 20020133176 | Parkin et al. | Sep 2002 | A1 |
| 20020151826 | Ramey et al. | Oct 2002 | A1 |
| 20020151908 | Mallett, Sr. et al. | Oct 2002 | A1 |
| 20020162863 | Brincat | Nov 2002 | A1 |
| 20020188261 | Hruska | Dec 2002 | A1 |
| 20020198488 | Yao | Dec 2002 | A1 |
| 20030012415 | Cossel | Jan 2003 | A1 |
| 20030018252 | Duchon et al. | Jan 2003 | A1 |
| 20030060834 | Muldner | Mar 2003 | A1 |
| 20030093040 | Mikszta et al. | May 2003 | A1 |
| 20030093089 | Greenberg | May 2003 | A1 |
| 20030097139 | Karasiuk | May 2003 | A1 |
| 20030135388 | Martucci et al. | Jul 2003 | A1 |
| 20030167032 | Ignon et al. | Sep 2003 | A1 |
| 20030187462 | Chang | Oct 2003 | A1 |
| 20030208159 | Ignon | Nov 2003 | A1 |
| 20030212127 | Glassman et al. | Nov 2003 | A1 |
| 20030212415 | Karasiuk | Nov 2003 | A1 |
| 20040005349 | Neev | Jan 2004 | A1 |
| 20040010222 | Nunomura et al. | Jan 2004 | A1 |
| 20040010269 | Grimes et al. | Jan 2004 | A1 |
| 20040015139 | La Bianco | Jan 2004 | A1 |
| 20040087972 | Mulholland et al. | May 2004 | A1 |
| 20040092895 | Harmon | May 2004 | A1 |
| 20040092959 | Bernaz | May 2004 | A1 |
| 20040097967 | Ignon | May 2004 | A1 |
| 20040122447 | Harmon et al. | Jun 2004 | A1 |
| 20040127914 | Chung | Jul 2004 | A1 |
| 20040138680 | Twitchell et al. | Jul 2004 | A1 |
| 20040143274 | Shadduck | Jul 2004 | A1 |
| 20040162565 | Carson et al. | Aug 2004 | A1 |
| 20040166172 | Rosati et al. | Aug 2004 | A1 |
| 20040176823 | Island et al. | Sep 2004 | A1 |
| 20040210280 | Liedtke | Oct 2004 | A1 |
| 20040219179 | McDaniel | Nov 2004 | A1 |
| 20040229295 | Marchitto et al. | Nov 2004 | A1 |
| 20040236291 | Zelickson et al. | Nov 2004 | A1 |
| 20040236375 | Redding, Jr. | Nov 2004 | A1 |
| 20040243149 | Lee, Jr. | Dec 2004 | A1 |
| 20040254587 | Park | Dec 2004 | A1 |
| 20040267285 | Chang | Dec 2004 | A1 |
| 20050015077 | Kuklin et al. | Jan 2005 | A1 |
| 20050037034 | Rhoades | Feb 2005 | A1 |
| 20050038377 | Redding, Jr. | Feb 2005 | A1 |
| 20050038448 | Chung | Feb 2005 | A1 |
| 20050059940 | Weber et al. | Mar 2005 | A1 |
| 20050065461 | Redding, Jr. | Mar 2005 | A1 |
| 20050070977 | Molina | Mar 2005 | A1 |
| 20050075599 | Redding, Jr. | Apr 2005 | A1 |
| 20050080465 | Zelickson et al. | Apr 2005 | A1 |
| 20050084509 | Bernstein | Apr 2005 | A1 |
| 20050148958 | Rucinski | Jul 2005 | A1 |
| 20050154333 | Mulholland et al. | Jul 2005 | A1 |
| 20050203111 | David | Sep 2005 | A1 |
| 20050203593 | Shanks et al. | Sep 2005 | A1 |
| 20050209611 | Greenberg | Sep 2005 | A1 |
| 20050245180 | Suissa | Nov 2005 | A1 |
| 20050283176 | Law | Dec 2005 | A1 |
| 20060002960 | Zoeteweij et al. | Jan 2006 | A1 |
| 20060015059 | Redding, Jr. | Jan 2006 | A1 |
| 20060058714 | Rhoades | Mar 2006 | A1 |
| 20060100567 | Marchitto et al. | May 2006 | A1 |
| 20060116674 | Goble et al. | Jun 2006 | A1 |
| 20060161178 | Lee | Jul 2006 | A1 |
| 20060184071 | Klopotek | Aug 2006 | A1 |
| 20060189964 | Anderson | Aug 2006 | A1 |
| 20060191562 | Numomura | Aug 2006 | A1 |
| 20060200099 | La Bianco et al. | Sep 2006 | A1 |
| 20060200172 | Shadduck | Sep 2006 | A1 |
| 20060200173 | Shadduck | Sep 2006 | A1 |
| 20060200213 | McDaniel | Sep 2006 | A1 |
| 20060212025 | McDaniel | Sep 2006 | A1 |
| 20060212029 | Villacampa et al. | Sep 2006 | A1 |
| 20060222445 | Chuang | Oct 2006 | A1 |
| 20060235371 | Wakamatsu et al. | Oct 2006 | A1 |
| 20060253078 | Wu et al. | Nov 2006 | A1 |
| 20060253079 | McDonough et al. | Nov 2006 | A1 |
| 20060253125 | Ignon | Nov 2006 | A1 |
| 20060264893 | Sage, Jr. et al. | Nov 2006 | A1 |
| 20060264926 | Kochamba | Nov 2006 | A1 |
| 20060269580 | Cole et al. | Nov 2006 | A1 |
| 20060278661 | Cooper et al. | Dec 2006 | A1 |
| 20070005078 | Hart et al. | Jan 2007 | A1 |
| 20070020321 | Redding et al. | Jan 2007 | A1 |
| 20070043382 | Cheney | Feb 2007 | A1 |
| 20070049901 | Wu et al. | Mar 2007 | A1 |
| 20070065515 | Key | Mar 2007 | A1 |
| 20070073327 | Giovannoli | Mar 2007 | A1 |
| 20070078290 | Esenaliev | Apr 2007 | A1 |
| 20070088245 | Babaev et al. | Apr 2007 | A1 |
| 20070088371 | Karasiuk | Apr 2007 | A1 |
| 20070093694 | Fassullotis et al. | Apr 2007 | A1 |
| 20070123808 | Rhoades | May 2007 | A1 |
| 20070139630 | Kleman et al. | Jun 2007 | A1 |
| 20070149991 | Mulholland | Jun 2007 | A1 |
| 20070154502 | Hattendorf et al. | Jul 2007 | A1 |
| 20070156124 | Ignon et al. | Jul 2007 | A1 |
| 20070178121 | First et al. | Aug 2007 | A1 |
| 20070198031 | Kellogg | Aug 2007 | A1 |
| 20070208353 | Shadduck | Sep 2007 | A1 |
| 20070232987 | Diaz et al. | Oct 2007 | A1 |
| 20070239079 | Manstein et al. | Oct 2007 | A1 |
| 20070239173 | Khalaj | Oct 2007 | A1 |
| 20070255355 | Altshuler et al. | Nov 2007 | A1 |
| 20070264625 | DeBenedictis et al. | Nov 2007 | A1 |
| 20070270738 | Wu et al. | Nov 2007 | A1 |
| 20080009802 | Lambino et al. | Jan 2008 | A1 |
| 20080015555 | Manstein et al. | Jan 2008 | A1 |
| 20080027328 | Klopotek et al. | Jan 2008 | A1 |
| 20080027518 | Island et al. | Jan 2008 | A1 |
| 20080091126 | Greenburg | Apr 2008 | A1 |
| 20080091179 | Durkin et al. | Apr 2008 | A1 |
| 20080103563 | Powell | May 2008 | A1 |
| 20080119781 | King | May 2008 | A1 |
| 20080132914 | Bossard et al. | Jun 2008 | A1 |
| 20080139974 | Da Silva | Jun 2008 | A1 |
| 20080146970 | Litman et al. | Jun 2008 | A1 |
| 20080154161 | Abbott | Jun 2008 | A1 |
| 20080154183 | Baker et al. | Jun 2008 | A1 |
| 20080161799 | Stangenes et al. | Jul 2008 | A1 |
| 20080188840 | Johnson et al. | Aug 2008 | A1 |
| 20080193493 | Rhoades | Aug 2008 | A1 |
| 20080200861 | Shalev et al. | Aug 2008 | A1 |
| 20080200863 | Chomas et al. | Aug 2008 | A1 |
| 20080208146 | Brandwein et al. | Aug 2008 | A1 |
| 20080208179 | Chan et al. | Aug 2008 | A1 |
| 20080214987 | Xu | Sep 2008 | A1 |
| 20080215068 | Hart et al. | Sep 2008 | A1 |
| 20080221548 | Danenberg et al. | Sep 2008 | A1 |
| 20080234626 | Chelak | Sep 2008 | A1 |
| 20080243039 | Rhoades | Oct 2008 | A1 |
| 20080287864 | Rosenberg | Nov 2008 | A1 |
| 20080300529 | Reinstein | Dec 2008 | A1 |
| 20080300552 | Cichocki et al. | Dec 2008 | A1 |
| 20090048557 | Yeshurun et al. | Feb 2009 | A1 |
| 20090053390 | Sakou et al. | Feb 2009 | A1 |
| 20090062815 | Karasluk et al. | Mar 2009 | A1 |
| 20090099091 | Hantash | Apr 2009 | A1 |
| 20090099093 | Hantash | Apr 2009 | A1 |
| 20090118684 | Da Silva et al. | May 2009 | A1 |
| 20090124985 | Hasenoehrl et al. | May 2009 | A1 |
| 20090132012 | Shanks | May 2009 | A1 |
| 20090138026 | Wu | May 2009 | A1 |
| 20090171191 | Patrick et al. | Jul 2009 | A1 |
| 20090171194 | Patrick et al. | Jul 2009 | A1 |
| 20090177171 | Gnon et al. | Jul 2009 | A1 |
| 20090192442 | Ignon et al. | Jul 2009 | A1 |
| 20090222023 | Boone, III et al. | Sep 2009 | A1 |
| 20090254014 | Son | Oct 2009 | A1 |
| 20090299237 | Rhoades | Dec 2009 | A1 |
| 20100023003 | Mulholland | Jan 2010 | A1 |
| 20100036298 | Fuster | Feb 2010 | A1 |
| 20100045427 | Boone, III et al. | Feb 2010 | A1 |
| 20100048980 | De Jong et al. | Feb 2010 | A1 |
| 20100049177 | Boone, III et al. | Feb 2010 | A1 |
| 20100049210 | Boone, III et al. | Feb 2010 | A1 |
| 20100056847 | De Jong et al. | Mar 2010 | A1 |
| 20100063565 | Beerwerth et al. | Mar 2010 | A1 |
| 20100217357 | Da Silva | Aug 2010 | A1 |
| 20100305495 | Anderson et al. | Dec 2010 | A1 |
| 20110054490 | Hart | Mar 2011 | A1 |
| 20110060270 | Eppstein | Mar 2011 | A1 |
| 20110066162 | Cohen | Mar 2011 | A1 |
| 20110082415 | Ignon et al. | Apr 2011 | A1 |
| 20110067761 | King | Jun 2011 | A1 |
| 20110190726 | Hantash et al. | Aug 2011 | A1 |
| 20110251523 | Kim | Oct 2011 | A1 |
| 20110264028 | Ramdas et al. | Oct 2011 | A1 |
| 20110270137 | Goren et al. | Nov 2011 | A1 |
| 20110270364 | Kreindel | Nov 2011 | A1 |
| 20110295273 | Waldron et al. | Dec 2011 | A1 |
| 20120022435 | Ignon et al. | Jan 2012 | A1 |
| 20120041338 | Chickering, III et al. | Feb 2012 | A1 |
| 20120041523 | Solomon et al. | Feb 2012 | A1 |
| 20120109041 | Munz | May 2012 | A1 |
| 20120109043 | Zhou et al. | May 2012 | A1 |
| 20120136374 | Karasiuk | May 2012 | A1 |
| 20120171636 | Groman | Jul 2012 | A1 |
| 20120259252 | Thorn-Leeson et al. | Oct 2012 | A1 |
| 20120289885 | Cottrell | Nov 2012 | A1 |
| 20120302929 | Tkachenko | Nov 2012 | A1 |
| 20130004230 | Kirk, III et al. | Jan 2013 | A1 |
| 20130018317 | Bobroff et al. | Jan 2013 | A1 |
| 20130066336 | Boone, III et al. | Mar 2013 | A1 |
| 20130085421 | Gillespie et al. | Apr 2013 | A1 |
| 20130096546 | Mirkov et al. | Apr 2013 | A1 |
| 20130096577 | Shadduck | Apr 2013 | A1 |
| 20130102978 | Ignon et al. | Apr 2013 | A1 |
| 20130144207 | Gonon | Jun 2013 | A1 |
| 20130144280 | Eckhouse et al. | Jun 2013 | A1 |
| 20130158547 | David | Jun 2013 | A1 |
| 20130204238 | Lederman et al. | Aug 2013 | A1 |
| 20130226075 | Hennings et al. | Aug 2013 | A1 |
| 20130226269 | Eckhouse et al. | Aug 2013 | A1 |
| 20130261534 | Niezgoda et al. | Oct 2013 | A1 |
| 20130268032 | Neev | Oct 2013 | A1 |
| 20130310906 | Neev | Nov 2013 | A1 |
| 20130317314 | Lampson | Nov 2013 | A1 |
| 20130345616 | Chang | Dec 2013 | A1 |
| 20140031801 | Giovannoli | Jan 2014 | A1 |
| 20140079686 | Barman et al. | Mar 2014 | A1 |
| 20140081251 | Giovannoli | Mar 2014 | A1 |
| 20140094718 | Feldman | Apr 2014 | A1 |
| 20140114234 | Redding, Jr. | Apr 2014 | A1 |
| 20140135798 | David | May 2014 | A1 |
| 20140234004 | Thorpe et al. | Aug 2014 | A1 |
| 20140243589 | Rowan | Aug 2014 | A1 |
| 20140316492 | Min et al. | Oct 2014 | A1 |
| 20140343481 | Ignon | Nov 2014 | A1 |
| 20140343574 | Ignon et al. | Nov 2014 | A1 |
| 20140378887 | Chang et al. | Dec 2014 | A1 |
| 20150032047 | Ignon et al. | Jan 2015 | A1 |
| 20150039060 | Paulussen et al. | Feb 2015 | A1 |
| 20150141877 | Feldman | May 2015 | A1 |
| 20150157496 | Horton et al. | Jun 2015 | A1 |
| 20150202007 | Mainstein et al. | Jul 2015 | A1 |
| 20150230824 | Shadduck | Aug 2015 | A1 |
| 20150230825 | Shadduck | Aug 2015 | A1 |
| 20150231379 | Ignon et al. | Aug 2015 | A1 |
| 20150265822 | Ignon et al. | Sep 2015 | A1 |
| 20150272623 | Ignon et al. | Oct 2015 | A1 |
| 20150290442 | Ignon et al. | Oct 2015 | A1 |
| 20150313993 | Bock | Nov 2015 | A1 |
| 20150351868 | Groman | Dec 2015 | A1 |
| 20160015962 | Maragheh et al. | Jan 2016 | A1 |
| 20160018100 | Batt et al. | Jan 2016 | A1 |
| 20160038183 | Ignon et al. | Feb 2016 | A1 |
| 20160175609 | Dye et al. | Jun 2016 | A1 |
| 20160220849 | Knowlton | Aug 2016 | A1 |
| 20160235257 | Daffer | Aug 2016 | A1 |
| 20160250415 | Yagi et al. | Sep 2016 | A1 |
| 20160270850 | Manstein et al. | Sep 2016 | A1 |
| 20160270851 | Moench et al. | Sep 2016 | A1 |
| 20160287333 | Morrison | Oct 2016 | A1 |
| 20160324578 | Manstein et al. | Nov 2016 | A1 |
| 20170036002 | Ignon et al. | Feb 2017 | A1 |
| 20170043150 | Kim | Feb 2017 | A1 |
| 20170065801 | Ignon et al. | Mar 2017 | A1 |
| 20170065829 | Ku | Mar 2017 | A1 |
| 20170106206 | Seckel | Apr 2017 | A1 |
| 20170128319 | Decaux et al. | May 2017 | A1 |
| 20170157419 | Jeong | Jun 2017 | A1 |
| 20170196759 | Palomaki et al. | Jul 2017 | A1 |
| 20170209894 | Sporrer | Jul 2017 | A1 |
| 20170252105 | Deem et al. | Sep 2017 | A1 |
| 20170291007 | Dubey et al. | Oct 2017 | A1 |
| 20170340356 | Presser et al. | Nov 2017 | A1 |
| 20170343308 | Wojciechowski, III et al. | Nov 2017 | A1 |
| 20180008500 | Anderson et al. | Jan 2018 | A1 |
| 20180140329 | Beljens et al. | May 2018 | A1 |
| 20180185675 | Kem et al. | Jul 2018 | A1 |
| 20180310979 | Peled et al. | Nov 2018 | A1 |
| 20180318568 | Ignon et al. | Nov 2018 | A1 |
| 20180326191 | Bansal et al. | Nov 2018 | A1 |
| 20190009110 | Gross et al. | Jan 2019 | A1 |
| 20190009111 | Myhr et al. | Jan 2019 | A1 |
| 20190070069 | Gertner et al. | Mar 2019 | A1 |
| 20190076193 | Clementi et al. | Mar 2019 | A1 |
| 20190083161 | Harle et al. | Mar 2019 | A1 |
| 20190133642 | Ignon et al. | May 2019 | A1 |
| 20190143089 | Ignon et al. | May 2019 | A1 |
| 20190151637 | Groop et al. | May 2019 | A1 |
| 20190168016 | Anderson et al. | Jun 2019 | A1 |
| 20190183562 | Widgerow | Jun 2019 | A1 |
| 20190209859 | Quisenberry et al. | Jul 2019 | A1 |
| 20190223914 | Ignon et al. | Jul 2019 | A1 |
| 20190224501 | Burdette | Jul 2019 | A1 |
| 20190239939 | Boll et al. | Aug 2019 | A1 |
| 20190240110 | Sedic | Aug 2019 | A1 |
| 20190240502 | Anderson et al. | Aug 2019 | A1 |
| 20190257320 | Petit et al. | Aug 2019 | A1 |
| 20190274759 | Royon et al. | Sep 2019 | A1 |
| 20190275320 | Kim et al. | Sep 2019 | A1 |
| 20190336740 | Ignon et al. | Nov 2019 | A1 |
| 20190366067 | Ginggen et al. | Dec 2019 | A1 |
| 20200009007 | Shadduck | Jan 2020 | A1 |
| 20200016342 | Ignon | Jan 2020 | A1 |
| 20200030627 | Eltorai et al. | Jan 2020 | A1 |
| 20200093945 | Jeong | Mar 2020 | A1 |
| 20200101312 | Pai et al. | Apr 2020 | A1 |
| 20200114116 | Dubey et al. | Apr 2020 | A1 |
| 20200121354 | Ginggen et al. | Apr 2020 | A1 |
| 20200171288 | Ignon et al. | Jun 2020 | A1 |
| 20200171289 | Ignon et al. | Jun 2020 | A1 |
| 20200179220 | Jablow | Jun 2020 | A1 |
| 20200206072 | Capelli et al. | Jul 2020 | A1 |
| 20200254273 | Jafari et al. | Aug 2020 | A1 |
| 20200275945 | Knowlton | Sep 2020 | A1 |
| 20200288843 | Verheem | Sep 2020 | A1 |
| 20200289161 | Scooros | Sep 2020 | A1 |
| 20200306555 | Ebbesson | Oct 2020 | A1 |
| 20200316270 | Dijkstra et al. | Oct 2020 | A1 |
| 20200330754 | Kim et al. | Oct 2020 | A1 |
| 20200338586 | Park | Oct 2020 | A1 |
| 20200367961 | Podmore et al. | Nov 2020 | A1 |
| 20200390468 | Alexander | Dec 2020 | A1 |
| 20210001148 | Verheem | Jan 2021 | A1 |
| 20210052292 | Karni | Feb 2021 | A1 |
| 20210085367 | Shadduck et al. | Mar 2021 | A1 |
| 20210128416 | Danto | May 2021 | A1 |
| 20210145479 | Ignon et al. | May 2021 | A1 |
| 20210145480 | Ignon et al. | May 2021 | A1 |
| 20210145481 | Ignon et al. | May 2021 | A1 |
| 20210154093 | Boone, III et al. | May 2021 | A1 |
| 20210154453 | Ignon et al. | May 2021 | A1 |
| 20210154454 | Ignon et al. | May 2021 | A1 |
| 20210154455 | Ignon et al. | May 2021 | A1 |
| 20210170150 | Hong et al. | Jun 2021 | A1 |
| 20210177463 | Ignon et al. | Jun 2021 | A1 |
| 20210220631 | Ok et al. | Jul 2021 | A1 |
| 20210236342 | Long et al. | Aug 2021 | A1 |
| 20210236347 | Carver | Aug 2021 | A1 |
| 20210236836 | Schwarz et al. | Aug 2021 | A1 |
| 20210242657 | Yi et al. | Aug 2021 | A1 |
| 20210259914 | Holbert | Aug 2021 | A1 |
| 20210267625 | Carver | Sep 2021 | A1 |
| 20210268304 | Lee | Sep 2021 | A1 |
| 20210275406 | Danto | Sep 2021 | A1 |
| 20210282855 | Boinagrov et al. | Sep 2021 | A1 |
| 20210283421 | Kang et al. | Sep 2021 | A1 |
| 20210290430 | Kim | Sep 2021 | A1 |
| 20210330356 | Del Rosario et al. | Oct 2021 | A1 |
| 20210353922 | Ignon et al. | Nov 2021 | A1 |
| 20210361525 | Park et al. | Nov 2021 | A1 |
| 20210370049 | Moss et al. | Dec 2021 | A1 |
| 20210370089 | Anash | Dec 2021 | A1 |
| 20210393478 | Bhatt | Dec 2021 | A1 |
| 20210393974 | Kim et al. | Dec 2021 | A1 |
| 20210393975 | Eltoral et al. | Dec 2021 | A1 |
| 20210395071 | Zubrum et al. | Dec 2021 | A1 |
| 20210402208 | Edgar | Dec 2021 | A1 |
| 20220001198 | Lee | Jan 2022 | A1 |
| 20220001199 | Beerwerth et al. | Jan 2022 | A1 |
| 20220008122 | Johnston et al. | Jan 2022 | A1 |
| 20220032082 | Shenfarber et al. | Feb 2022 | A1 |
| 20220054189 | Wootten | Feb 2022 | A1 |
| 20220071491 | Bae et al. | Mar 2022 | A1 |
| 20220072332 | Park et al. | Mar 2022 | A1 |
| 20220087891 | Goodman et al. | Mar 2022 | A1 |
| 20220111198 | Jung | Apr 2022 | A1 |
| 20220117632 | Walker et al. | Apr 2022 | A1 |
| 20220125706 | Horinek et al. | Apr 2022 | A1 |
| 20220126014 | Cederna et al. | Apr 2022 | A1 |
| 20220133407 | Anderson et al. | May 2022 | A1 |
| 20220175443 | Slatkine et al. | Jun 2022 | A1 |
| 20220176092 | Quan et al. | Jun 2022 | A1 |
| 20220203112 | Iger et al. | Jun 2022 | A1 |
| 20220211424 | Wootten et al. | Jul 2022 | A1 |
| 20220211988 | Ignon et al. | Jul 2022 | A1 |
| 20220218562 | Capelli et al. | Jul 2022 | A1 |
| 20220226668 | Lee et al. | Jul 2022 | A1 |
| 20220233400 | Oh et al. | Jul 2022 | A1 |
| 20220241107 | Kim et al. | Aug 2022 | A1 |
| 20220241146 | Jeong | Aug 2022 | A1 |
| 20220268536 | Stephenson et al. | Aug 2022 | A1 |
| 20220287910 | Boone, III et al. | Sep 2022 | A9 |
| 20220312940 | Hong et al. | Oct 2022 | A1 |
| 20220362529 | Castro | Nov 2022 | A1 |
| 20220401714 | Quan et al. | Dec 2022 | A1 |
| 20220409276 | Choi | Dec 2022 | A1 |
| 20230012684 | Ignon et al. | Jan 2023 | A1 |
| 20230014299 | Lee, Jr. et al. | Jan 2023 | A1 |
| 20230018295 | Ignon et al. | Jan 2023 | A1 |
| 20230019979 | Deem et al. | Jan 2023 | A1 |
| 20230033217 | Ignon et al. | Feb 2023 | A1 |
| 20230033761 | Ignon et al. | Feb 2023 | A1 |
| 20230042047 | Kim et al. | Feb 2023 | A1 |
| 20230062185 | Nazarian et al. | Mar 2023 | A1 |
| 20230104221 | Aharon | Apr 2023 | A1 |
| 20230123145 | Ko | Apr 2023 | A1 |
| 20230158282 | Ignon et al. | May 2023 | A1 |
| Number | Date | Country |
|---|---|---|
| 400305 | Dec 1995 | AT |
| 1014299 | May 1999 | AU |
| 2340154 | Sep 2002 | CA |
| 2784209 | Aug 2011 | CA |
| 1708261 | Dec 2005 | CN |
| 107920948 | Apr 2018 | CN |
| 306995346 | Dec 2021 | CN |
| 308188687 | Aug 2023 | CN |
| 599521 | Jul 1934 | DE |
| 2415633 | Oct 1975 | DE |
| 3338057 | Aug 1984 | DE |
| 3421390 | Dec 1985 | DE |
| 234608 | Apr 1986 | DE |
| 3503343 | Aug 1986 | DE |
| 8330191 | Jun 1987 | DE |
| 3740902 | Dec 1988 | DE |
| 4237940 | May 1993 | DE |
| 29808395 | Aug 1998 | DE |
| 10-2004-015815 | Nov 2005 | DE |
| 0258901 | Sep 1987 | EP |
| 0479121 | Apr 1992 | EP |
| 0564392 | Mar 1993 | EP |
| 0784997 | Jul 1997 | EP |
| 1238643 | Apr 2000 | EP |
| 1453558 | Sep 2004 | EP |
| 2206483 | Jul 2010 | EP |
| 2544563 | Sep 2015 | EP |
| 2106780 | Mar 2016 | EP |
| 2865867 | May 2016 | EP |
| 3217899 | May 2016 | EP |
| 2240099 | Feb 2018 | EP |
| 2967633 | Apr 2018 | EP |
| 3302319 | Apr 2018 | EP |
| 3319573 | May 2018 | EP |
| 3340908 | Jul 2018 | EP |
| 2451367 | Jan 2020 | EP |
| 3388006 | Mar 2020 | EP |
| 2618797 | Apr 2020 | EP |
| 3237055 | Aug 2020 | EP |
| 3795204 | Mar 2021 | EP |
| 3437575 | Apr 2021 | EP |
| 8794184-0001 | Dec 2021 | EP |
| 8880371-0001 | May 2022 | EP |
| 015024621-0002 | Jun 2023 | EP |
| 1037776 | Apr 1998 | ES |
| 2712172 | May 1995 | FR |
| 2773461 | Jul 1999 | FR |
| 1372609 | Oct 1974 | GB |
| 2306351 | May 1997 | GB |
| 2585500 | Jan 2021 | GB |
| 553076 | Dec 1956 | IT |
| 1184922 | Mar 1985 | IT |
| 53-118927 | Aug 1963 | JP |
| H05-042060 | Feb 1993 | JP |
| 1993-088552 | Dec 1993 | JP |
| 1997-294747 | Nov 1997 | JP |
| 2003-534881 | Nov 2003 | JP |
| 2003-339713 | Dec 2003 | JP |
| 2004-275721 | Oct 2004 | JP |
| 2006-503627 | Feb 2006 | JP |
| 2006-204767 | Oct 2006 | JP |
| 2010-042243 | Feb 2010 | JP |
| 2012-527967 | Nov 2012 | JP |
| 2013-215621 | Oct 2013 | JP |
| 5508285 | Mar 2014 | JP |
| D1581877 | Jul 2017 | JP |
| D1609357 | Jun 2018 | JP |
| 2018-527052 | Sep 2018 | JP |
| 20-0280320 | Jul 2002 | KR |
| 10-20070070173 | Jul 2007 | KR |
| 10-2018-0030607 | Mar 2018 | KR |
| 10-1836310 | Mar 2018 | KR |
| D214226 | Sep 2021 | TW |
| WO 1994024980 | Nov 1994 | WO |
| WO 1997000707 | Jan 1997 | WO |
| WO 1997011650 | Mar 1997 | WO |
| WO 199923951 | May 1999 | WO |
| WO 2000015300 | Mar 2000 | WO |
| WO 200079540 | Dec 2000 | WO |
| WO 200193931 | Dec 2001 | WO |
| WO 2004108091 | Dec 2001 | WO |
| WO 2003073917 | Sep 2003 | WO |
| WO 2004037098 | May 2004 | WO |
| WO 2004037287 | May 2004 | WO |
| WO 2005061042 | Jul 2005 | WO |
| WO 2005070313 | Aug 2005 | WO |
| WO 2006018731 | Feb 2006 | WO |
| WO 2006031413 | Mar 2006 | WO |
| WO 2007114904 | Oct 2007 | WO |
| WO 2008012324 | Jan 2008 | WO |
| WO 2009086182 | Jul 2009 | WO |
| WO 2009088884 | Jul 2009 | WO |
| WO 2009097451 | Aug 2009 | WO |
| WO 2010022396 | Feb 2010 | WO |
| WO 2010068960 | Jun 2010 | WO |
| WO 2010151704 | Dec 2010 | WO |
| WO 2011006009 | Jan 2011 | WO |
| WO 2011110840 | Sep 2011 | WO |
| WO 2012131623 | Oct 2012 | WO |
| WO 2012145667 | Oct 2012 | WO |
| WO 2013030117 | Mar 2013 | WO |
| WO 2014091035 | Jun 2014 | WO |
| WO 2014151104 | Sep 2014 | WO |
| WO 2016052818 | Apr 2016 | WO |
| WO 2016106396 | Jun 2016 | WO |
| WO 2017007939 | Jan 2017 | WO |
| WO 2017111481 | Jun 2017 | WO |
| WO 2021018765 | Feb 2021 | WO |
| WO 2021113343 | Jun 2021 | WO |
| WO 2022099318 | May 2022 | WO |
| WO 2023039524 | Mar 2023 | WO |
| WO 2023064718 | Apr 2023 | WO |
| WO 2023164572 | Aug 2023 | WO |
| Entry |
|---|
| U.S. Appl. No. 09/648,025 (now U.S. Pat. No. 6,641,591), filed Aug. 25, 2000, Instruments and Techniques for Controlled Removal of Epidermal Layers. |
| U.S. Appl. No. 10/699,747 (now U.S. Pat. No. 7,789,886), filed Nov. 3, 2003, Instruments and Techniques for Controlled Removal of Epidermal Layers. |
| U.S. Appl. No. 11/739,615 (now U.S. Pat. No. 8,337,513), filed Apr. 24, 2007, Instruments and Techniques for Controlled Removal of Epidermal Layers. |
| U.S. Appl. No. 11/417,709 (now U.S. Pat. No. 8,066,716), filed May 3, 2006, Instruments and Techniques for Controlled Removal of Epidermal Layers. |
| U.S. Appl. No. 11/417,396 (now U.S. Pat. No. 7,678,120), filed May 3, 2006, Instruments and Techniques for Controlled Removal of Epidermal Layers. |
| U.S. Appl. No. 14/702,509 (now U.S. Pat. No. 9,775,646), filed May 1, 2015, Devices and Systems for Treating the Skin Using Vacuum. |
| U.S. Appl. No. 14/702,486 (now U.S. Pat. No. 9,468,464), filed May 1, 2015, Methods for Treating the Skin Using Vacuum. |
| U.S. Appl. No. 11/392,348 (now U.S. Pat. No. 8,048,089), filed Mar. 29, 2006, Apparatus and Methods for Treating the Skin. |
| U.S. Appl. No. 13/267,554 (now U.S. Pat. No. 9,474,886), filed Oct. 6, 2011, Removable Tips for Skin Treatment Systems. |
| U.S. Appl. No. 14/698,673 (now U.S. Pat. No. 9,550,052), filed Apr. 28, 2015, Console System for the Treatment of Skin. |
| U.S. Appl. No. 14/698,713 (now U.S. Pat. No. 9,662,482), filed Apr. 28, 2015, Methods and Systems for Extraction of Materials From Skin. |
| U.S. Appl. No. 14/700,789 (now U.S. Pat. No. 9,814,868), filed Apr. 30, 2015, Tip With Embedded Materials for Skin Treatment. |
| U.S. Appl. No. 15/660,750 (now U.S. Pat. No. 10,357,641), filed Jul. 26, 2017, Tips for Skin Treatment Device. |
| U.S. Appl. No. 15/660,777 (now U.S. Pat. No. 10,357,642), filed Jul. 26, 2017, Removable Tips for Use With Skin Treatment Systems. |
| U.S. Appl. No. 16/517,268 (now U.S. Pat. No. 11,446,477), filed Jul. 19, 2019, Devices and Methods for Treating Skin. |
| U.S. Appl. No. 17/165,820 (now U.S. Pat. No. 11,547,840), filed Feb. 2, 2021, Devices and Methods for Treating Skin. |
| U.S. Appl. No. 17/165,807 (now U.S. Pat. No. 11,612,726), filed Feb. 2, 2021, Devices and Methods for Treating Skin. |
| U.S. Appl. No. 18/094,884, filed Jan. 9, 2023, Devices and Methods for Treating Skin. |
| U.S. Appl. No. 09/294,254 (now U.S. Pat. No. 6,162,232), filed Apr. 19, 1999, Instruments and Techniques for High-Velocity Fluid Abrasion of Epidermal Layers With Skin Cooling. |
| U.S. Appl. No. 09/475,480 (now U.S. Pat. No. 6,299,620), filed Dec. 30, 1999, Instruments and Techniques for Inducing Neocollagenesis in Skin Treatments. |
| U.S. Appl. No. 09/475,479 (now U.S. Pat. No. 6,384,103), filed Dec. 30, 1999, Instruments and Techniques for Inducing Neocollagenesis in Skin Treatments. |
| U.S. Appl. No. 11/370,200, filed Mar. 7, 2006, Microdermabrasion Method and Apparatus. |
| U.S. Appl. No. 12/362,353 (now U.S. Pat. No. 9,056,193), filed Jan. 29, 2009, Apparatus and Method for Treating the Skin. |
| U.S. Appl. No. 14/734,995 (now U.S. Pat. No. 11,020,577), filed Jun. 9, 2015, Devices and Systems for Treating Skin Surfaces. |
| U.S. Appl. No. 17/332,897, filed May 27, 2021, Devices, Systems, and Methods for Treating the Skin. |
| U.S. Appl. No. 17/952,569 (present application), filed Sep. 26, 2022, Devices, Systems, and Methods for Treating the Skin. |
| U.S. Appl. No. 17/952,665, filed Sep. 26, 2022, Devices, Systems, and Methods for Treating the Skin. |
| U.S. Appl. No. 12/832,663 (now U.S. Pat. No. 8,814,836), filed Jul. 8, 2010, Devices, Systems and Methods for Treating the Skin Using Time-Release Substances. |
| U.S. Appl. No. 14/455,762 (now U.S. Pat. No. 9,642,997), filed Aug. 8, 2014, Devices for Treating Skin Using Treatment Materials Located Along a Tip. |
| U.S. Appl. No. 15/588,102 (now U.S. Pat. No. 10,556,097), filed May 5, 2017, Devices for Treating Skin Using Treatment Materials Located Along a Tip. |
| U.S. Appl. No. 16/784,850, filed Feb. 7, 2020, Devices and Methods for Treating Skin. |
| U.S. Appl. No. 12/346,582 (now U.S. Pat. No. 8,343,116), filed Dec. 30, 2008, Apparatus and Method for Treating the Skin. |
| U.S. Appl. No. 13/620,376 (now U.S. Pat. No. 9,486,615), filed Sep. 14, 2012, Microdermabrasion Apparatus and Method. |
| U.S. Appl. No. 15/344,357 (now U.S. Pat. No. 10,556,096), filed Nov. 4, 2016, Devices and Methods for Skin Treatment. |
| U.S. Appl. No. 16/784,044, filed Feb. 6, 2020, Devices and Methods for Skin Treatment. |
| U.S. Appl. No. 09/540,945 (now U.S. Pat. No. 6,592,595), filed Mar. 31, 2000, Microdermabrasion and Suction Massage Apparatus and Method. |
| U.S. Appl. No. 09/698,409 (now U.S. Pat. No. 6,527,783), filed Oct. 27, 2000, Microdermabrasion and Suction Massage Apparatus and Method. |
| U.S. Appl. No. 10/177,173 (now U.S. Pat. No. 6,673,082), filed Jun. 20, 2002, Microdermabrasion Handpiece With Supply and Return Lumens. |
| U.S. Appl. No. 10/315,478 (now U.S. Pat. No. 6,942,649), filed Dec. 10. 2002, Microdermabrasion Fluid Application System and Method. |
| U.S. Appl. No. 09/699,220 (now U.S. Pat. No. 6,629,983), filed Oct. 27, 2000, Apparatus and Method for Skin/Surface Abrasion. |
| U.S. Appl. No. 14/211,089 (now U.S. Pat. No. 10,238,812), filed Mar. 14, 2014, Skin Treatment Systems and Methods Using Needles. |
| U.S. Appl. No. 16/363,310, filed Mar. 25, 2019, Skin Treatment Systems and Methods Using Needles. |
| U.S. Appl. No. 14/211,290 (now U.S. Pat. No. 9,566,088), filed Mar. 14, 2014, Devices, Systems and Methods for Treating the Skin. |
| U.S. Appl. No. 15/430,209 (now U.S. Pat. No. 10,251,675), filed Feb. 10, 2017, Devices, Systems and Methods for Treating the Skin. |
| U.S. Appl. No. 16/376,956 (now U.S. Pat. No. 11,717,326), filed Apr. 5, 2019, Devices, Systems and Methods for Treating the Skin. |
| U.S. Appl. No. 17/952,721, filed Sep. 26, 2022, Devices, Systems, and Methods for Treating the Skin. |
| U.S. Appl. No. 17/952,676, filed Sep. 26, 2022, Devices, Systems, and Methods for Treating the Skin. |
| U.S. Appl. No. 14/774,641, filed Sep. 10, 2015, Devices, Systems and Methods for Treating the Skin. |
| U.S. Appl. No. 16/241,572, filed Jan. 7, 2019, Devices, Systems and Methods for Treating the Skin. |
| U.S. Appl. No. 17/163,128, filed Jan. 29, 2021, Devices, Systems and Methods for Treating the Skin. |
| U.S. Appl. No. 17/163,199 (now U.S. Pat. No. 11,517,350), filed Jan. 29, 2021, Devices, Systems and Methods for Treating the Skin. |
| U.S. Appl. No. 17/163,237 (now U.S. Pat. No. 11,202,657), filed Jan. 29, 2021, Devices, Systems and Methods for Treating the Skin. |
| U.S. Appl. No. 17/163,240 (now U.S. Pat. No. 11,213,321), filed Jan. 29, 2021, Devices, Systems and Methods for Treating the Skin. |
| U.S. Appl. No. 14/998,375 (now U.S. Pat. No. 9,498,610), filed Dec. 23, 2015, Devices and Methods for Treating the Skin Using a Rollerball or a Wicking Member. |
| U.S. Appl. No. 15/354,754 (now U.S. Pat. No. 10,035,007), filed Nov. 17, 2016, Devices and Methods for Treating the Skin. |
| U.S. Appl. No. 16/040,397, filed Jul. 19, 2018, Devices and Methods for Treating the Skin. |
| U.S. Appl. No. 17/164,580, filed Feb. 1, 2021, Devices and Methods for Treating the Skin. |
| U.S. Appl. No. 15/498,416 (now U.S. Pat. No. 10,179,229), filed Apr. 26, 2017, Devices and Methods for Treating the Skin Using a Porous Member. |
| U.S. Appl. No. 16/246,306 (now U.S. Pat. No. 11,224,728), filed Jan. 11, 2019, Devices and Methods for Treating the Skin Using a Porous Member. |
| U.S. Appl. No. 17/576,888, filed Jan. 14, 2022, Devices and Methods for Treating the Skin. |
| U.S. Appl. No. 15/204,939 (now U.S. Pat. No. 11,241,357), filed Jul. 7, 2016, Devices, Systems and Methods for Promoting Hair Growth. |
| U.S. Appl. No. 17/592,432, filed Feb. 3, 2022, Devices, Systems and Methods for Improving Scalp Health. |
| U.S. Appl. No. 18/035,723, filed May 5, 2023, Devices, Systems and Methods for Treating the Skin. |
| U.S. Appl. No. 29/811,066, filed Oct. 11, 2021, Skin Treatment System. |
| U.S. Appl. No. 29/807,430, filed Sep. 10, 2021, Skin Treatment Device. |
| U.S. Appl. No. 29/807,428, filed Sep. 10, 2021, Container for a Skin Treatment Device. |
| U.S. Appl. No. 29/829,476, filed Mar. 4, 2022, Light Therapy Device for Skin Care. |
| U.S. Appl. No. 29/811,070, filed Oct. 11, 2021, Skin Treatment Tip. |
| U.S. Appl. No. 29/826,153, filed Feb. 9, 2022, Dual Treating Device for Treating Acne or Wrinkles. |
| U.S. Appl. No. 29/854,067, filed Sep. 21, 2022, Treatment Device for Skin. |
| U.S. Appl. No. 29/884,441, filed Feb. 10, 2023, Skin Treatment Tip. |
| Amazon, FAZJEUNE 7 Color LED Light, LED Face Mask Skin Rejevenation PDT Photon Facial Skin Care Mask Skin Tightening Lamp SPA Face Device Beauty Salon Equipment Anti-aging RemoveWrinkle, Customer reviewed on Sep. 2020, retrieved from internet at https://www.amazon.com/FAZJEUNE-Rejuvenation-Tightening-Equipment-Anti-aging/dp/B08B4M8RQQ/ref=psdc_11061121_t3_B08ZSPZSF4. |
| Cox III et al., Decreased Splatter in Dermabrasion, Arch Facial Plastic Surgery, Jan.-Mar. 2000, vol. 2, pp. 23-26. |
| Ditre et al., Effect of a-hydroxy acids on photoaged skin: A pilot clinical, histologic, and ultrastructural study, Journal of American Academy of Dermatology, Feb. 1996, vol. 34, No. 2, Part 1, pp. 187-195. |
| Harris et al., Combining Manual Dermasanding with Low Strength Trichloroacetic Acid to Improve Antinically Injured Skin, the Journal of Dermatologic Surgery and Oncology, Jul. 1994, vol. 20, No. 7, pp. 436-442. |
| Hydrafacial® Tower—User guide. Edge Systems. Revised Jun. 23, 2016. p. 16. |
| Microdermabrader Pepita Instruction Manual, Mattioli Engineering S.R.L., PEP_USA2.doc Rev 1.1, Sep. 29, 1997. |
| International Search Report and Written Opinion for related PCT appl. PCT/US2010/041430 dated Jan. 19, 2012. |
| International Search Report and Written Opinion for related PCT appl. PCT/US2009/032465 dated Mar. 18, 2009. |
| Beautimate adjustable Hydra Needle Microneedling Serium Applicator, https://www.beautimate.com/products/adjustable-hydra-needle, first accessed Aug. 12, 2023. |
| Hydrafacial Hydropeel Vortex Fusion Tips, https://mergesouq.com/products/hydrafacial-hydropeel-vortex-fusion-tips, first accessed Aug. 12, 2023. |
| “BeautyBio: GLOfacial Hydro-Infusion deep pore cleansing + Blue LED clarifying tool”, found online at amazon.com Sep. 26, 2023, ref. dated Nov. 15, 2022, retrieved https://www.amazon.com/GLOfacial-Hyrdo-Infusion-Deep-Cleansing-Clarifying/dp/B0BGJLMSZP/. |
| “Healthline: What is a HydraFacial and how does it work”, found online at healthline.com Sep. 26, 2023, Ref. dated Dec. 9, 2020, https://www.healthline.com/health/what-is-hydrafacial. |
| “InStyle: Why the HydraFacial is one of the most popular in-office treatments”, found online at instyle.com on Sep. 26, 2023, ref. dated Jun. 12, 2023, https://www.instyle.com/beauty/skin/hydrafacial-treatment-facts. |
| “Microderm Glo: Glo Mini”, found online at microdermglo.com Sep. 26, 2023, ref. dated Sep. 27, 2019, https://www.microdermglo.com/collections/microdermabrasion-machines. |
| Number | Date | Country | |
|---|---|---|---|
| 20230012684 A1 | Jan 2023 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61024504 | Jan 2008 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 17332897 | May 2021 | US |
| Child | 17952569 | US | |
| Parent | 14734995 | Jun 2015 | US |
| Child | 17332897 | US | |
| Parent | 12362353 | Jan 2009 | US |
| Child | 14734995 | US |
